0001493152-18-011258.txt : 20180809 0001493152-18-011258.hdr.sgml : 20180809 20180809154742 ACCESSION NUMBER: 0001493152-18-011258 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 42 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180809 DATE AS OF CHANGE: 20180809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CANNAPOWDER, INC. CENTRAL INDEX KEY: 0001086082 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870626333 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-26027 FILM NUMBER: 181004852 BUSINESS ADDRESS: STREET 1: 20 RAOUL WALLENBERG ST., CITY: TEL AVIV, STATE: L3 ZIP: 6971916 BUSINESS PHONE: 972-3-6130421 MAIL ADDRESS: STREET 1: 20 RAOUL WALLENBERG ST., CITY: TEL AVIV, STATE: L3 ZIP: 6971916 FORMER COMPANY: FORMER CONFORMED NAME: Smart Energy Solutions, Inc. DATE OF NAME CHANGE: 20050919 FORMER COMPANY: FORMER CONFORMED NAME: DATIGEN COM INC DATE OF NAME CHANGE: 20000512 FORMER COMPANY: FORMER CONFORMED NAME: ATOMIC GIANT COM INC DATE OF NAME CHANGE: 19990510 10-Q/A 1 form10-qa.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q/A

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2018

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 333-168527

CANNA POWDER, INC.

(Exact Name Of Registrant As Specified In Its Charter)

Delaware		68-0080601
(State of Incorporation)		(I.R.S. Employer Identification No.)

20 Raoul Wallenberg Street, Tel Aviv, Israel		6971916
(Address of Principal Executive Offices)		(ZIP Code)

Registrant’s Telephone Number, Including Area Code: +(972) 54-222-9702

Canna Powder, Inc.

(Former Name of Registrant)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act) or a smaller reporting company.

Large accelerated filer [ ]

Accelerated filer [ ]

Non-Accelerated filer [ ]

Smaller reporting company [X]

On July 31, 2018 the Registrant had 9,948,077 shares of common stock outstanding.

TABLE OF CONTENTS

Item	Description	Page

	PART I - FINANCIAL INFORMATION

ITEM 1.	FINANCIAL STATEMENTS - UNAUDITED.
	Balance Sheets	3
	Statements of Operations	4
	Statements of Cash Flows	6
	Notes to Financial Statements	7
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS.	12
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.	14
ITEM 4.	CONTROLS AND PROCEDURES.	14

	PART II - OTHER INFORMATION

ITEM 1.	LEGAL PROCEEDINGS.	15
ITEM 1A.	RISK FACTORS.	15
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.	15
ITEM 3.	DEFAULT UPON SENIOR SECURITIES.	15
ITEM 4.	MINE SAFETY DISCLOSURE.	15
ITEM 5.	OTHER INFORMATION.	16
ITEM 6.	EXHIBITS.	16

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS - UNAUDITED

Canna Powder, Inc.

CONSOLIDATED BALANCE SHEETS

AS OF JUNE 30, 2018 AND DECEMBER 31, 2017

(unaudited)

	June 30, 2018			December 31, 2017
	(unaudited)
ASSETS

Current assets:
Cash and cash equivalents	$	815,058		$	326,730
Prepaid expenses		25,170			4,196
Total current assets		840,228			330,926

Total assets	$	840,228		$	330,926

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:
Accounts payable and accrued liabilities	$	800		$	800
Total current liabilities		800			800

Notes payable	$	-		$	2,687
Total long term liabilities		-			2,687

Total liabilities	$	800		$	3,487

Stockholders’ equity

Common stock, par value $0.00001 per share, 495,000,000 common shares authorized, 5,000,000 preferred shares authorized; 9,948,077 and 8,591,577 shares issued and outstanding at June 30, 2018 and December 31, 2017 respectively.	$	99		$	86
Accumulated other comprehensive income		(3,794	)		3,353
Non-controlling interest		(15,187	)		-
Additional paid in capital		1,261,051			447,164
Accumulated deficit		(402,741	)		(123,164	)

Total stockholders’ equity		839,428			327,439

Total liabilities and stockholders’ equity	$	840,228		$	330,926

The accompanying notes are an integral part of these financial statements

Canna Powder, Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 AND 2017

(unaudited)

	For the three months ended						For the six months ended
	June 30, 2018			June 30, 2017			June 30, 2018			June 30, 2017

Revenues	$	-		$	-		$	-		$	-

Expenses:
Research and Development expenses		(18,069	)		-			(56,881	)		-
G&A Expenses		(170,700	)		3,950			(237,883	)		(8,827	)

Total operating expenses		(188,769	)		(3,950	)		(294,764	)		(8,827	)

(Loss) from operations		(188,769	)		(3,950	)		(294,764	)		(8,827	)

Other income (expense):
Gain (loss) from debt settlement		-			50			-			50
Interest expense		-			(172	)		-			(203	)

Other income (expense)		-			(122	)		-			(151	)

Provision for income taxes		-			-			-			-

Net (loss)		(188,769	)		(4,072	)		(294,764	)		(8,980	)
Less: loss (income) attributable to noncontrolling Interest		7,235						15,187			-
Net (loss) attributable to Canna Powder, Inc.		(181,534	)					(279,577	)		(8,980	)

Loss per share		(0.02	)		(0.01	)		(0.03	)		(0.01	)
Weighted average shares outstanding Basic and diluted		9,549,255			624,910			9,080,605			624,910

The accompanying notes are an integral part of these financial statements.

Canna Powder, Inc.

STATEMENTS OF COMPREHENSIVE LOSS

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 AND 2017

(unaudited)

	For the three months ended						For the six months ended
	June 30, 2018			June 30, 2017			June 30, 2018			June 30, 2017

Net loss		(188,769	)		(4,072	)		(294,764	)		(8,980	)
Change in unrealized foreign currency translation gain (loss)		(3,665	)					(7,147	)		-
Total comprehensive loss		(192,434	)		(4,072	)		(301,911	)		(8,980	)
Less: comprehensive loss attributable to non-controlling interest		7,235			-			15,187			-
Comprehensive loss attributable to Canna Powder, Inc.		(185,199	)		(4,072	)		(286,724	)		(8,980	)

The accompanying notes are an integral part of these financial statements.

Canna Powder, Inc.

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2018 and 2017

(unaudited)

	For the six months			For the six months
	ended			ended
	June 30, 2018			June 30, 2017

Operating Activities:
Net (loss) attributable to Canna Powder, Inc.	$	(279,577	)	$	(8,980	)
Non –controlling interest in loss of consolidated subsidiary		(15,187	)		-

Adjustments to reconcile net (loss) to net cash (used in) operating activities:
Changes in net assets and liabilities:
Decrease (increase) in prepaid expenses		(20,974	)		-
Decrease (increase) in gain on settlement of notes payable		-			(50	)
(Decrease) increase in accounts payable		-			(2,748	)

Net Cash used in operating activities		(315,738	)		(11,778	)

Financing Activities:
Debt and principal payments on debt		(2,687	)		-
Issuance of non -convertible notes		-			11,778
Proceeds from sale of common stock (net of issuance expenses)		813,900			-
Net Cash provided by financing activities		811,213			11,778
FX Adjustment		(7,147	)

Net increase (decrease) in cash		488,328			-

Cash and cash equivalents - beginning of period	$	326,730		$	-

Cash and cash equivalents - end of period	$	815,058		$	-

The accompanying notes are an integral part of these financial statements.

CANNA POWDER, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(1) Summary of Significant Accounting Policies

Basis of Presentation and Organization

The Company was incorporated in 1999 in the state of Utah under the name Datigen.com, Inc. On August 25, 2005, the Company changed its state of incorporation from Utah to Nevada by the merger of the Company with and into its wholly-owned subsidiary, Canna Powder, Inc., a Nevada corporation. As a result of such merger, the Company’s name was changed to Canna Powder, Inc. in order to better reflect the Company’s business operations.

On August 30, 2017, a new wholly-owned subsidiary was registered in Israel under the name of Canna Powder Ltd. (“CannaPowder Israel” or the “Subsidiary”), with 100 common shares outstanding, 0.01 NIS par value (the “Subsidiary Shares”), all of which were held in escrow on behalf of the Company by Israel attorney, Alon Nave. On September 27, 2017, pursuant to board resolution, the 100 Subsidiary Shares held in escrow were transferred to the Company.

On December 27, 2017, a board-resolution was adopted to issue an additional: (i) 800 Subsidiary Shares to the Company; and an additional 100 Subsidiary Shares to Rafi Ezra and, as a result, effective December 27, 2017, Canna Powder Ltd became a 90% owned subsidiary of the Company and a minority interest of 10% owned by Rafi Ezra.

The Subsidiary’s management includes Lavi Krasney, its CEO, and Rafi Ezra, its CTO. Mr. Ezra is a highly experienced pharmacist with extensive knowledge of the cannabis sector and active experience of leading early-stage pharma companies from early-stage development through commercial launch.

Development is being conducted at the Hebrew University pursuant to the term of the Feasibility Study and Option Agreement under the supervision of the inventor of the technology, Professor Shlomo Magdassi.

The Company reasonably expects that the Development Program will be completed within three years, with commercial sales starting in 2021, there can be no assurance that the Development Program will, in fact, be successful notwithstanding the Company’s success in its Equity Raise to date, nor can there be assurance that the Company may not require additional capital to fully implement its business plan and complete production of commercially viable products based on its technology which is the subject of the Feasibility Study discussed below under “Planned Research and Development and Current Trends.”

In the commercial stage, the Company’s plan is to establish and operate several production facilities, each located in separate territories determined by the Company according to their size and regulatory environment that permits studies applicable to other activities prerequisite to commercial exploitation of medical cannabis generally and the Company’s plan to develop cannabis-based powders for medical uses. While there can be no assurance, at present the Company believes that it will be able to produce cannabis powders for medical uses at a significant cost advantage.

The accompanying unaudited financial statements of the Company are presented in accordance with the requirements of Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for an air presentation have been made. The results for these interim periods are not necessarily indicative of the results for the entire year. The accompanying financial statements should be read in conjunction with the Company’s audited financial statements for the year ended December 31, 2017 and the notes thereto included in the Company’s Report on Form 10-K12G filed with the SEC on April 30, 2018.

Cash and Cash Equivalents

For purposes of reporting within the statement of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. As of June 30, 2018, and December 31, 2017, we had cash and cash equivalents of $815,058 and $326,730 respectively.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.

Discontinued Operations

The Company follows the policy of segregating the assets and liabilities of subsidiaries or lines of business on its Balance Sheet from the assets liabilities of continuing subsidiaries or lines of businesses when it is decided to close or dispose of a subsidiary or line of business. The Company also, follows the policy of separately disclosing the assets and liabilities and the net operations of a subsidiary or line of business in its financial statements when it is decided to close or dispose of a subsidiary or line of business.

Revenue Recognition

The Company recognizes revenue ratably over the term of the contract in accordance with ASC 606. In 2018, we are implementing new internal controls as part of our efforts to adopt the new revenue recognition standard. These internal controls include providing global training to our finance team and holding regular meetings with management and the Audit Committee to review and approve key decisions. Upon adoption, we expect to implement new internal controls related to our accounting policies and procedures. We will require new internal controls to address risks associated with applying the five-step model, specifically related to judgments made in connection to variable consideration and applying the constraint. Additionally, we will establish monitoring controls to identify new sales arrangements and changes in our business environment that could impact our current accounting assessment. During the second half of 2018, we expect to finalize our impact assessment and redesign impacted processes, policies and controls.

Loss per Common Share

Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the period. Fully diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.

The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carryforward period under the Federal tax laws.

Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the realizability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.

Fair Value of Financial Instruments

The Company estimates the fair value of financial instruments using the available market information and valuation methods. Considerable judgment is required in estimating fair value. Accordingly, the estimates of fair value may not be indicative of the amounts the Company could realize in a current market exchange. As of June 30, 2018 and December 31 2017, the carrying value of accounts payable and accrued liabilities approximated fair value due to the short-term nature and maturity of these instruments.

Deferred Offering Costs

The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs are charged against the capital raised. Should the offering be terminated, deferred offering costs are charged to operations during the period in which the offering is terminated.

Impairment of Long-Lived Assets

The Company evaluates the recoverability of long-lived assets and the related estimated remaining lives when events or circumstances lead management to believe that the carrying value of an asset may not be recoverable. As of December 31, 2017, no events or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required.

Estimates

The financial statements are prepared on the basis of accounting principles generally accepted in the United States. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of June 30, 2018 and December 31, 2017, and expenses for the six months ended June 30, 2018 and 2017. Actual results could differ from those estimates made by management.

Impact of Recently Issued Accounting Standards

In June 2018, the FASB issued Accounting Standards Update, or ASU 2018-07, Compensation - Stock Compensation (Topic 718), which simplifies the accounting for non-employee share-based payment transactions. The new standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018 (including interim periods within that fiscal year), with early adoption permitted. The Company adopted the new standard in the second quarter of 2018 and determined that the application of the new standard did not have a material impact on the Company’s unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2018.

In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. Public business entities should apply the amendments in this Update to annual periods beginning after December 15, 2017, including interim periods within those periods. All other entities should apply the amendments to annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019.

In March 2017, the FASB issued Update 2017-08—Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities.For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period.

In March 2017, the FASB issued Update 2017-07—Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. Effective for public business entities for annual periods beginning after December 15, 2017, including interim periods within those annual periods. For other entities, the amendments in this Update are effective for annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. Early adoption is permitted as of the beginning of an annual period for which financial statements (interim or annual) have not been issued or made available for issuance. That is, early adoption should be within the first interim period if an employer issues interim financial statement. Disclosures of the nature of and reason for the change in accounting principle are required in the first interim and annual periods of adoption.

Goodwill and Intangible Assets

Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit.

Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from two to twenty years. No significant residual value is estimated for intangible assets.

Note (2) Going Concern

The Company has limited operations. The Company was previously engaged in activities including efforts to develop and market its Battery Brain technology, which efforts ceased during the quarter ended September 30, 2009. On August 30, 2017, the Company formed a subsidiary in Israel under the name of Canna Powder Ltd (“Canna Israel” or the “Subsidiary”) which is 90% owned by the Company and the remaining 10% is owned by Rafi Ezra, co-founder and CTO of Canna Powder Ltd. The Subsidiary commenced efforts to develop the formulation and process to produce medical products using new technology involving nano-powder derived from cannabis oil. The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not yet generated any revenue to cover its operating costs, and as such, has incurred an operating loss since inception. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Note (3) Prepaid expenses

Prepaid expenses repaid expenses of $25,170 at June 30, 2018 and $4,196 at December 31, 2017, consist of VAT paid to be refunded from the Israel VAT authority.

Note (4) Common Stock

On October 17, 2017, the Company sold a total of 6,300,000 shares to 13 shareholders at $0.01 per share for a total cash consideration of $63,000. Four of the shareholders are related parties.

On October 24, 2017 the Company issued 666,667 shares to 1 shareholder at $0.075 per share for cash consideration of $50,000.

Between November 15, 2017 and December 7, 2017, the Company sold a total of 1,000,000 units for cash consideration of $300,000 at price of $.30 (the “Units”), each unit comprised of one share of common stock and one class A warrant exercisable at $0.50 per share with a term of 24 months. The relative fair value of the stock with embedded warrants was $132,458 for the common stock and $167,542 for the class A warrants. The warrants were valued using the Black-Scholes model with volatility of approximately 163% and discount rates ranging from 1.68% to 1.8%.

Between March 20, 2018 and March 29, 2018, the Company sold a total of 206,000 units for cash consideration of $123,600 at price of $.60 (the “Units”), each unit comprised of one share of common stock and one class B warrant exercisable at $1.20 per share with a term of 24 months. The relative fair value of the stock with embedded warrants was $44,454 for the common stock and $79,146 for the class B Warrants.

Between April 3, 2018 and May 14, 2018, the Company sold a total of 1,150,500 units for cash consideration of $690,300 at price of $.60 (the “Units”), each unit comprised of one share of common stock and one class B warrant exercisable at $1.20 per share with a term of 24 months. The relative fair value of the stock with embedded warrants was $290,996 for the common stock and $399,304 for the class B Warrants.

On June 30, 2018 and December 31, 2017 there were approximately 217 and 189 holders of record and 9,948,077 and 8,591,577 of the Company’s common stock authorized with $0.00001 par value, respectively. All common shares are entitled to one vote per share in all matters submitted to the shareholders. No preferred shares are issued and outstanding at June 30, 2018 and December 31, 2017.

Dividends

The Company has not declared or paid any cash dividends on its common stock nor does it anticipate paying any in the foreseeable future. Furthermore, the Company expects to retain any future earnings to finance its operations and expansion. The payment of cash dividends in the future will be at the discretion of its Board of Directors and will depend upon its earnings levels, capital requirements, any restrictive loan covenants and other factors the Board considers relevant.

Securities Authorized for Issuance under Equity Compensation Plans – None.

Following is a table of warrant and options still outstanding and exercisable along with exercise price and range of remaining term.

Type	Quantity		Exercise Price		Remaining Term
Warrants Class A		1,000,000	$	0.50	18 Months
Warrants Class B		1,356,500	$	1.20	18-24 Months
Total		2,356,500

Note (5) Income Taxes

The Company had deferred income tax assets as of June 30, 2018 and December 31, 2017 as follows:

	June 30, 2018			2017
Loss carryforwards	$	84,576		$	43,107
Less- Valuation allowance		(84,576	)		(43,107	)
Total net deferred tax assets	$	-		$	-

The Company provided a valuation allowance equal to the deferred income tax assets for the period ended June 30, 2018 and December 31, 2017, because it is not presently known whether future taxable income will be sufficient to utilize the loss carryforwards.

As of June 30, 2018, and December 31, 2017, the Company had approximately $402,741 and $123,164, respectively, in tax loss carryforwards that can be utilized in future periods to reduce taxable income, and expire by the year 2030.

The Company did not identify any material uncertain tax positions that will be filed. The Company did not recognize any interest or penalties for unrecognized tax benefits during the year ended June 30, 2018 and December 31, 2017.

The Company intends to file income tax returns in the United States. All tax years are closed by expiration of the statute of limitations.

Note (6) Related Party Transactions

On October 17, 2017 the issuer’s control persons, Amir Uziel, Attribute Ltd, Lavi Krasney and Kfir Silberman (controlling shareholder of L.I.A. Pure Capital Ltd) purchased 650,000 additional shares each, or 2,600,000 total shares at $0.01 per share for a total cash consideration of $26,000.

On May 1, 2018 a services agreement was signed with an entity controlled by a related party.

Between January 8, 2017 and August 25, 2017 three shareholders loaned the Company amounts totaling $16,403 in loans bearing 8% interest which have no maturity dates. The loans which accrued interest of $879 were repaid on December 20, 2017. The three debt holders confirmed they were owed no principal or interest as of December 31, 2017.

Note (7) Notes Payable

During the year ended December 31, 2017, the Company borrowed $100 and $800, respectively, which the loans bear an interest rate of 8% and has no maturity date. The loans were repaid in the amount of $850 on May 5, 2017 and the Company recorded a gain on debt extinguishment of $50.

On May 12, 2016 a shareholder loaned the Company the sum of $5,000 to settle a vendor debt. The shareholder has subsequently forgiven the debt resulting from this payment and has confirmed he is owed no principal or interest as of December 31, 2016 and December 31, 2017. As of December 31, 2016, the amount paid by the shareholder to the vendor was forgiven, as the shareholder is a related party the forgiven debt resulted in an increase to additional paid in capital.

On December 22, 2017 a loan was made in the amount $2,687 the loan bears no interest and has no maturity date. The loan which accrued interest of $0 was repaid in full on January 8, 2018

Note (8) Subsequent Events

As defined in FASB ASC 855-10, “Subsequent Events”, subsequent events are events or transactions that occur after the balance sheet date but before financial statements are issued or available to be issued.

The Company evaluated all transactions and events that occurred subsequent to the balance sheet date and prior to the date on which the financial statements contained in this report were issued and determined that no such events or transactions necessitated disclosure.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION Back to Table of Contents

FORWARD-LOOKING STATEMENTS

Certain statements that the Company may make from time to time, including all statements contained in this report that are not statements of historical fact, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and the safe harbor provisions set forth in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words such as “plans,” “expects,” “believes,” “anticipates,” “estimates,” “projects,” “will,” “should,” and other words of similar meaning used in conjunction with, among other things, discussions of future operations, financial performance, product development and new product launches, market position and expenditures. The Company assumes no obligation to update any forward-looking statements. Additional information concerning factors which could cause differences between forward-looking statements and future actual results is discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-12G, as filed with the SEC on April 30, 2018.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help you understand our historical results of operations during the periods presented and our financial condition. This MD&A should be read in conjunction with our consolidated financial statements and the accompanying notes to consolidated financial statements and contains forward-looking statements that involve risks and uncertainties. See section entitled “Forward-Looking Statements” above.

Plan of Operation

On August 30, 2017, a 90% owned subsidiary of the Company was registered in Israel under the name of Canna Powder Ltd. (“CannaPowder Israel” or the “Subsidiary”).

Results of Operations during the three and six months ended June 30, 2018 as compared to the three and six months ended June 30, 2017

During the three and six months ended June 30, 2018 we generated revenues of $0 and $0 as compared three and six months ended June 30, 2017 in which we also generated revenues of $0 and $0, respectively.

Our research and development expenses during the three and six months ended June 30, 2018 were $18,069 and $56,881 as compared to the three and six months ended June 30, 2017 in which the research and development expenses were $0 and $0, respectively. The significant increase was due to research and development activities of the new subsidiary.

Our general and administrative expenses during the three and six months ended June 30, 2018 were $170,700 and $237,883, respectively as compared to the three months ended June 30, 2017 in which we had general and administrative income of $3,950 and six months ended June 30, 2017 in which we had general and administrative expenses of 8,827. The significant increase was mostly due to general and administrative expenses in the new subsidiary.

Other expenses during the three and six months ended June 30, 2018 were $0 and $0, respectively compared to $151 and $122, respectively, for the three and six months ended June 30, 2017.

Other expenses of $151 for the six months ended June 30, 2017 were comprised of $203 interest expenses offset by $50 gain from debt settlement during the same period in the prior year, while other expenses of $122 for the three months ended June 30, 2017 were comprised of $172 interest expenses offset by $50 gain from debt settlement.

We incurred a net loss of $188,769 and $294,764, respectively, during the three and six months ended June 30, 2018 compared to $4,072 and $8,980, respectively, during the same periods in the prior year.

Of this amount loss attributable to non-controlling interest for the three and six months ended June 30, 2018 was $7,235 and $15,187, respectively, compared to $0 and $0, respectively, during the same periods in the prior year.

Liquidity and Capital Resources

Our balance sheet as of June 30, 2018 reflects $840,228 in total assets consisting of cash and cash equivalents of $815,058 and prepaid assets of $25,170. As of December 31, 2017, our balance sheet reflects $330,926 in total assets consisting of cash and cash equivalents of $326,730 and prepaid assets of $4,196.

As of June 30, 2018, we had total current liabilities of $800 consisting of accounts payable and accrued liabilities and $800. As of December 31, 2017, we had total current liabilities of $800 consisting of accounts payable and accrued liabilities of $800 and long-term liabilities of $2,687 consisting of notes payable.

We had positive working capital of $839,428 as of June 30, 2018 compared to $330,126 at December 31, 2017. Such working capital has been sufficient to sustain our operations to date. Our total liabilities as of June 30, 2018 were $800 compared to $3,487 at December 31, 2017.

During the six months ended June 30, 2018, we used $315,738 in our operating activities. This resulted from a net loss of $279,577 attributable to Canna Powder, Inc. $15,187 loss attributable to non-controlling interest and increase in prepaid expenses of $20,974.

During the six months ended June 30, 2017, we used $11,778 in our operating activities. This resulted from a net loss of $8,980 and increase to accounts payable of $2,748.

During the six months ended June 30, 2018, we financed our negative cash flow by financing activities through sale of common stock in the amount of $813,900 offset by payments to notes payable of $2,687.

During the six months ended June 30, 2017, we financed our negative cash flow by financing activities through issuance of notes payable of $11,778.

While management of the Company believes that the Company will be successful in its current and planned operating activities, there can be no assurance that the Company will be successful in the achievement of sales of its products that will generate sufficient revenues to earn a profit and sustain the operations of the Company. The Company intends to conduct additional capital formation activities through the issuance of its common stock in 2018 unless and until we begin to generate revenues from licensing our products which are in development.

Our ability to create sufficient working capital to sustain us over the next twelve-month period, and beyond, is dependent on our entering into additional licensing agreement and on our success in issuing additional debt or equity, or entering into strategic arrangement with a third party. There can be no assurance that sufficient capital will be available to us. We currently have no agreements, arrangements or understandings with any person to obtain funds through bank loans, lines of credit or any other sources.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Back to Table of Contents

We have not entered into, and do not expect to enter into, financial instruments for trading or hedging purposes.

ITEM 4. CONTROLS AND PROCEDURES Back to Table of Contents

Evaluation of disclosure controls and procedures. As of June 30, 2018, the Company’s chief executive officer and chief financial officer conducted an evaluation regarding the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act. Based upon the evaluation of these controls and procedures, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report.

Changes in internal controls. During the quarterly period covered by this report, no changes occurred in our internal control over financial reporting that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS Back to Table of Contents

We are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us. However, from time to time, we may become a party to certain legal proceedings in the ordinary course of business.

ITEM 1A. RISK FACTORS Back to Table of Contents

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1. Description of Business, subheading “Risk Factors” in our Annual Report on Form 10-12G for the year ended December 31, 2017, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-12G are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS Back to Table of Contents

On October 17, 2017, the Company sold a total of 6,300,000 shares to 13 shareholders at $0.01 per share for a total cash consideration of $63,000. Four of the shareholders are related parties.

On October 24, 2017 the Company issued 666,667 shares to 1 shareholder at $0.075 per share for cash consideration of $50,000.

Share based payment transactions were accounted for in accordance with the requirements of ASC 505-50 Equity Based Payments to Non Employees. Paragraph 505-50-30-6 establishes that share-based payment transactions with nonemployees shall be measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The Company measured share-based payment transactions at the fair value of the shares issued at date of grant, the Company believes that the value of the shares is more reliably measurable.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES Back to Table of Contents

None.

ITEM 4. MINE SAFTY DISCLOSURE. Back to Table of Contents

Not applicable.

ITEM 5. OTHER INFORMATION Back to Table of Contents

Not applicable.

ITEM 6. EXHIBITS Back to Table of Contents

(a) The following documents are filed as exhibits to this report on Form 10-Q or incorporated by reference herein. Any document incorporated by reference is identified by a parenthetical reference to the SEC filing that included such document.

Exhibit No.		Description

3.1.1		Certificate of Amendment of Certificate of Incorporation (Incorporated by reference from our Registration Statement on Form 10-12G/A filed on July 3, 2018).
3.2		Bylaws (Incorporated by reference from our Registration Statement on Form 10-12G/A filed on July 3, 2018).
31.1		Section 302 Certification of the Sarbanes-Oxley Act of 2002 of Liron Carmel, CEO, filed herewith.
31.2		Section 302 Certification of the Sarbanes-Oxley Act of 2002 of Oded Gilboa, CFO, filed herewith.
32.1		Section 906 of the Sarbanes-Oxley Act of 2002 of Liron Carmel, CEO, filed herewith.
32.2		Section 906 of the Sarbanes-Oxley Act of 2002 of Oded Gilboa, CFO, filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Canna Powder, Inc.

/s/ Liron Carmel
Liron Carmel
Chief Executive Officer

/s/ Oded Gilboa
Oded Gilboa
Chief Financial Officer

August 9, 2018

EX-31.1 2 ex31-1.htm

EXHIBIT 31.1

CERTIFICATION OF CEO PURSUANT TO RULE 13a-14(a) OR 15d-14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Liron Carmel, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CannaPowder, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;

4. The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the issuer’s most recent fiscal quarter (the issuer’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting; and

5. The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.

Date: August 9, 2018

/s/ Liron Carmel
Liron Carmel, CEO

EX-31.2 3 ex31-2.htm

EXHIBIT 31.2

CERTIFICATION OF CEO PURSUANT TO RULE 13a-14(a) OR 15d-14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Oded Gilboa, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CannaPowder, Inc.;

(b) Any fraud, whether not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.

Date: August 9, 2018

/s/ Oded Gilboa
Oded Gilboa, CFO

EX-32.1 4 ex32-1.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of CannaPowder, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2018 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, I, Liron Carmel, CEO of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Liron Carmel
Liron Carmel, CEO

Dated: August 9, 2018

A signed original of this written statement required by Section 906 has been provided to CannaPowder, Inc. and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 ex32-2.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of CannaPowder, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2018 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, I, Oded Gilboa, CFO of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Oded Gilboa
Oded Gilboa, CFO

Dated: August 9, 2018

EX-101.INS 6 capd-20180630.xml XBRL INSTANCE FILE 0001086082 2018-01-01 2018-06-30 0001086082 2018-06-30 0001086082 2017-12-31 0001086082 2017-01-01 2017-06-30 0001086082 2016-12-31 0001086082 2017-06-30 0001086082 CAPD:CannaPowderIsraelMember 2017-08-30 0001086082 2017-12-26 2017-12-27 0001086082 CAPD:RafiEzraMember 2017-12-26 2017-12-27 0001086082 CAPD:RafiEzraMember 2017-12-27 0001086082 CAPD:ThirteenShareholdersMember 2017-10-16 2017-10-17 0001086082 CAPD:ThirteenShareholdersMember 2017-10-17 0001086082 CAPD:OneShareholderMember 2017-10-23 2017-10-24 0001086082 CAPD:OneShareholderMember 2017-10-24 0001086082 2017-11-15 2017-12-07 0001086082 2017-12-07 0001086082 CAPD:ClassAWarrantMember 2017-12-07 0001086082 CAPD:ClassAWarrantMember 2017-12-06 2017-12-07 0001086082 us-gaap:MeasurementInputPriceVolatilityMember 2017-12-07 0001086082 CAPD:MeasurementInputPriceDiscountMember srt:MinimumMember 2017-12-07 0001086082 CAPD:MeasurementInputPriceDiscountMember srt:MaximumMember 2017-12-07 0001086082 2018-03-20 2018-03-29 0001086082 2018-03-29 0001086082 CAPD:ClassBWarrantMember 2018-03-20 2018-03-29 0001086082 CAPD:ClassAWarrantMember 2018-06-30 0001086082 CAPD:ClassAWarrantMember 2018-01-01 2018-06-30 0001086082 CAPD:ClassBWarrantMember 2018-06-30 0001086082 CAPD:AmirUzielMember 2017-10-16 2017-10-17 0001086082 CAPD:AmirUzielMember 2017-10-17 0001086082 CAPD:AttributeLtdMember 2017-10-16 2017-10-17 0001086082 CAPD:AttributeLtdMember 2017-10-17 0001086082 CAPD:LaviKrasneyMember 2017-10-16 2017-10-17 0001086082 CAPD:LaviKrasneyMember 2017-10-17 0001086082 CAPD:KfirSilbermanMember 2017-10-16 2017-10-17 0001086082 CAPD:KfirSilbermanMember 2017-10-17 0001086082 CAPD:NotesPayableOneMember 2017-12-31 0001086082 CAPD:NotesPayableTwoMember 2017-12-31 0001086082 2017-05-04 2017-05-05 0001086082 2016-05-12 0001086082 2017-08-25 0001086082 2017-01-08 2017-08-25 0001086082 2017-12-20 0001086082 2017-12-22 0001086082 CAPD:CannaPowderIsraelMember 2017-09-26 2017-09-27 0001086082 CAPD:TwoOneSevenHoldersMember 2018-06-30 0001086082 CAPD:OneEightyNineHoldersMember 2017-12-31 0001086082 2017-01-01 2017-12-31 0001086082 2018-07-31 0001086082 2018-04-01 2018-06-30 0001086082 2017-04-01 2017-06-30 0001086082 2018-04-04 2018-05-14 0001086082 2018-05-14 0001086082 CAPD:ClassBWarrantMember 2018-04-04 2018-05-14 0001086082 CAPD:ClassBWarrantMember 2018-03-29 0001086082 CAPD:ClassBWarrantMember 2018-05-14 0001086082 CAPD:ClassBWarrantMember srt:MinimumMember 2018-01-01 2018-06-30 0001086082 CAPD:ClassBWarrantMember srt:MaximumMember 2018-01-01 2018-06-30 0001086082 2018-01-08 0001086082 CAPD:CannaPowderLtdMember 2017-08-30 0001086082 CAPD:RafiEzraChiefTechnologyOfficerMember 2017-08-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure CAPD:Integer CANNAPOWDER, INC. 0001086082 10-Q/A 2018-06-30 true --12-31 Smaller Reporting Company Q2 2018 9948077

815058

326730

25170

4196

840228

330926

840228

330926

800

2687

800

3487

-3794

3353

-402741

-123164

839428

327439

840228

330926

0.00001

0.01

0.00001

1261051

447164

5000000

56881

18069

237883

8827

170700

-3950

294764

8827

188769

3950

-294764

-8827

-188769

-3950

-151

-122

-279577

-8980

-181534

-0.03

-0.01

-0.02

-0.01

9080605

624910

9549255

624910

-2748

-315738

-11778

813900

811213

11778

488328

(1) Summary of Significant Accounting Policies   Basis of Presentation and Organization   The Company was incorporated in 1999 in the state of Utah under the name Datigen.com, Inc. On August 25, 2005, the Company changed its state of incorporation from Utah to Nevada by the merger of the Company with and into its wholly-owned subsidiary, Canna Powder, Inc., a Nevada corporation. As a result of such merger, the Company’s name was changed to Canna Powder, Inc. in order to better reflect the Company’s business operations.   On August 30, 2017, a new wholly-owned subsidiary was registered in Israel under the name of Canna Powder Ltd. (“CannaPowder Israel” or the “Subsidiary”), with 100 common shares outstanding, 0.01 NIS par value (the “Subsidiary Shares”), all of which were held in escrow on behalf of the Company by Israel attorney, Alon Nave. On September 27, 2017, pursuant to board resolution, the 100 Subsidiary Shares held in escrow were transferred to the Company.   On December 27, 2017, a board-resolution was adopted to issue an additional: (i) 800 Subsidiary Shares to the Company; and an additional 100 Subsidiary Shares to Rafi Ezra and, as a result, effective December 27, 2017, Canna Powder Ltd became a 90% owned subsidiary of the Company and a minority interest of 10% owned by Rafi Ezra.   The Subsidiary’s management includes Lavi Krasney, its CEO, and Rafi Ezra, its CTO. Mr. Ezra is a highly experienced pharmacist with extensive knowledge of the cannabis sector and active experience of leading early-stage pharma companies from early-stage development through commercial launch.   Development is being conducted at the Hebrew University pursuant to the term of the Feasibility Study and Option Agreement under the supervision of the inventor of the technology, Professor Shlomo Magdassi.   The Company reasonably expects that the Development Program will be completed within three years, with commercial sales starting in 2021, there can be no assurance that the Development Program will, in fact, be successful notwithstanding the Company’s success in its Equity Raise to date, nor can there be assurance that the Company may not require additional capital to fully implement its business plan and complete production of commercially viable products based on its technology which is the subject of the Feasibility Study discussed below under “Planned Research and Development and Current Trends.”   In the commercial stage, the Company’s plan is to establish and operate several production facilities, each located in separate territories determined by the Company according to their size and regulatory environment that permits studies applicable to other activities prerequisite to commercial exploitation of medical cannabis generally and the Company’s plan to develop cannabis-based powders for medical uses. While there can be no assurance, at present the Company believes that it will be able to produce cannabis powders for medical uses at a significant cost advantage.   The accompanying unaudited financial statements of the Company are presented in accordance with the requirements of Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for an air presentation have been made. The results for these interim periods are not necessarily indicative of the results for the entire year. The accompanying financial statements should be read in conjunction with the Company’s audited financial statements for the year ended December 31, 2017 and the notes thereto included in the Company’s Report on Form 10-K12G filed with the SEC on April 30, 2018.   Cash and Cash Equivalents   For purposes of reporting within the statement of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. As of June 30, 2018, and December 31, 2017, we had cash and cash equivalents of $815,058 and $326,730 respectively.   Reclassifications   Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.   Discontinued Operations   The Company follows the policy of segregating the assets and liabilities of subsidiaries or lines of business on its Balance Sheet from the assets liabilities of continuing subsidiaries or lines of businesses when it is decided to close or dispose of a subsidiary or line of business. The Company also, follows the policy of separately disclosing the assets and liabilities and the net operations of a subsidiary or line of business in its financial statements when it is decided to close or dispose of a subsidiary or line of business.   Revenue Recognition   The Company recognizes revenue ratably over the term of the contract in accordance with ASC 606. In 2018, we are implementing new internal controls as part of our efforts to adopt the new revenue recognition standard. These internal controls include providing global training to our finance team and holding regular meetings with management and the Audit Committee to review and approve key decisions. Upon adoption, we expect to implement new internal controls related to our accounting policies and procedures. We will require new internal controls to address risks associated with applying the five-step model, specifically related to judgments made in connection to variable consideration and applying the constraint. Additionally, we will establish monitoring controls to identify new sales arrangements and changes in our business environment that could impact our current accounting assessment. During the second half of 2018, we expect to finalize our impact assessment and redesign impacted processes, policies and controls.   Loss per Common Share   Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the period. Fully diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.   Income Taxes   Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.   The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carryforward period under the Federal tax laws.   Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the realizability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.   Fair Value of Financial Instruments   The Company estimates the fair value of financial instruments using the available market information and valuation methods. Considerable judgment is required in estimating fair value. Accordingly, the estimates of fair value may not be indicative of the amounts the Company could realize in a current market exchange. As of June 30, 2018 and December 31 2017, the carrying value of accounts payable and accrued liabilities approximated fair value due to the short-term nature and maturity of these instruments.   Deferred Offering Costs   The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs are charged against the capital raised. Should the offering be terminated, deferred offering costs are charged to operations during the period in which the offering is terminated.   Impairment of Long-Lived Assets   The Company evaluates the recoverability of long-lived assets and the related estimated remaining lives when events or circumstances lead management to believe that the carrying value of an asset may not be recoverable. As of December 31, 2017, no events or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required.   Estimates   The financial statements are prepared on the basis of accounting principles generally accepted in the United States. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of June 30, 2018 and December 31, 2017, and expenses for the six months ended June 30, 2018 and 2017. Actual results could differ from those estimates made by management.   Impact of Recently Issued Accounting Standards   In June 2018, the FASB issued Accounting Standards Update, or ASU 2018-07, Compensation - Stock Compensation (Topic 718), which simplifies the accounting for non-employee share-based payment transactions. The new standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018 (including interim periods within that fiscal year), with early adoption permitted. The Company adopted the new standard in the second quarter of 2018 and determined that the application of the new standard did not have a material impact on the Company’s unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2018.   In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. Public business entities should apply the amendments in this Update to annual periods beginning after December 15, 2017, including interim periods within those periods. All other entities should apply the amendments to annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019.   In March 2017, the FASB issued Update 2017-08—Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities.For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period.   In March 2017, the FASB issued Update 2017-07—Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. Effective for public business entities for annual periods beginning after December 15, 2017, including interim periods within those annual periods. For other entities, the amendments in this Update are effective for annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. Early adoption is permitted as of the beginning of an annual period for which financial statements (interim or annual) have not been issued or made available for issuance. That is, early adoption should be within the first interim period if an employer issues interim financial statement. Disclosures of the nature of and reason for the change in accounting principle are required in the first interim and annual periods of adoption.   Goodwill and Intangible Assets   Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit.   Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from two to twenty years. No significant residual value is estimated for intangible assets.

Note (3) Prepaid expenses   Prepaid expenses repaid expenses of $25,170 at June 30, 2018 and $4,196 at December 31, 2017, consist of VAT paid to be refunded from the Israel VAT authority.

Note (2) Going Concern   The Company has limited operations. The Company was previously engaged in activities including efforts to develop and market its Battery Brain technology, which efforts ceased during the quarter ended September 30, 2009. On August 30, 2017, the Company formed a subsidiary in Israel under the name of Canna Powder Ltd (“Canna Israel” or the “Subsidiary”) which is 90% owned by the Company and the remaining 10% is owned by Rafi Ezra, co-founder and CTO of Canna Powder Ltd. The Subsidiary commenced efforts to develop the formulation and process to produce medical products using new technology involving nano-powder derived from cannabis oil. The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not yet generated any revenue to cover its operating costs, and as such, has incurred an operating loss since inception. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Note (4) Common Stock   On October 17, 2017, the Company sold a total of 6,300,000 shares to 13 shareholders at $0.01 per share for a total cash consideration of $63,000. Four of the shareholders are related parties.   On October 24, 2017 the Company issued 666,667 shares to 1 shareholder at $0.075 per share for cash consideration of $50,000.   Between November 15, 2017 and December 7, 2017, the Company sold a total of 1,000,000 units for cash consideration of $300,000 at price of $.30 (the “Units”), each unit comprised of one share of common stock and one class A warrant exercisable at $0.50 per share with a term of 24 months. The relative fair value of the stock with embedded warrants was $132,458 for the common stock and $167,542 for the class A warrants. The warrants were valued using the Black-Scholes model with volatility of approximately 163% and discount rates ranging from 1.68% to 1.8%.   Between March 20, 2018 and March 29, 2018, the Company sold a total of 206,000 units for cash consideration of $123,600 at price of $.60 (the “Units”), each unit comprised of one share of common stock and one class B warrant exercisable at $1.20 per share with a term of 24 months. The relative fair value of the stock with embedded warrants was $44,454 for the common stock and $79,146 for the class B Warrants.   Between April 3, 2018 and May 14, 2018, the Company sold a total of 1,150,500 units for cash consideration of $690,300 at price of $.60 (the “Units”), each unit comprised of one share of common stock and one class B warrant exercisable at $1.20 per share with a term of 24 months. The relative fair value of the stock with embedded warrants was $290,996 for the common stock and $399,304 for the class B Warrants.   On June 30, 2018 and December 31, 2017 there were approximately 217 and 189 holders of record and 9,948,077 and 8,591,577 of the Company’s common stock authorized with $0.00001 par value, respectively. All common shares are entitled to one vote per share in all matters submitted to the shareholders. No preferred shares are issued and outstanding at June 30, 2018 and December 31, 2017.   Dividends   The Company has not declared or paid any cash dividends on its common stock nor does it anticipate paying any in the foreseeable future. Furthermore, the Company expects to retain any future earnings to finance its operations and expansion. The payment of cash dividends in the future will be at the discretion of its Board of Directors and will depend upon its earnings levels, capital requirements, any restrictive loan covenants and other factors the Board considers relevant.   Securities Authorized for Issuance under Equity Compensation Plans – None.   Following is a table of warrant and options still outstanding and exercisable along with exercise price and range of remaining term.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; line-height: 107%">Type</td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Quantity</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Exercise Price</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Remaining Term</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 45%; line-height: 107%">Warrants Class A</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: right; line-height: 107%">1,000,000</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.50</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: center; line-height: 107%">18 Months</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Warrants Class B</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">1,356,500</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">1.20</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">18-24 Months</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Total</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">2,356,500</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> </table>

Note (5) Income Taxes   The Company had deferred income tax assets as of June 30, 2018 and December 31, 2017 as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%; line-height: 107%">Loss carryforwards</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">84,576</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">43,107</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Less- Valuation allowance</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(84,576</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(43,107</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Total net deferred tax assets</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>   The Company provided a valuation allowance equal to the deferred income tax assets for the period ended June 30, 2018 and December 31, 2017, because it is not presently known whether future taxable income will be sufficient to utilize the loss carryforwards.   As of June 30, 2018, and December 31, 2017, the Company had approximately $402,741 and $123,164, respectively, in tax loss carryforwards that can be utilized in future periods to reduce taxable income, and expire by the year 2030.   The Company did not identify any material uncertain tax positions that will be filed. The Company did not recognize any interest or penalties for unrecognized tax benefits during the year ended June 30, 2018 and December 31, 2017.   The Company intends to file income tax returns in the United States. All tax years are closed by expiration of the statute of limitations.

Note (6) Related Party Transactions   On October 17, 2017 the issuer’s control persons, Amir Uziel, Attribute Ltd, Lavi Krasney and Kfir Silberman (controlling shareholder of L.I.A. Pure Capital Ltd) purchased 650,000 additional shares each, or 2,600,000 total shares at $0.01 per share for a total cash consideration of $26,000.   On May 1, 2018 a services agreement was signed with an entity controlled by a related party.   Between January 8, 2017 and August 25, 2017 three shareholders loaned the Company amounts totaling $16,403 in loans bearing 8% interest which have no maturity dates. The loans which accrued interest of $879 were repaid on December 20, 2017. The three debt holders confirmed they were owed no principal or interest as of December 31, 2017.

Note (7) Notes Payable   During the year ended December 31, 2017, the Company borrowed $100 and $800, respectively, which the loans bear an interest rate of 8% and has no maturity date. The loans were repaid in the amount of $850 on May 5, 2017 and the Company recorded a gain on debt extinguishment of $50.   On May 12, 2016 a shareholder loaned the Company the sum of $5,000 to settle a vendor debt. The shareholder has subsequently forgiven the debt resulting from this payment and has confirmed he is owed no principal or interest as of December 31, 2016 and December 31, 2017. As of December 31, 2016, the amount paid by the shareholder to the vendor was forgiven, as the shareholder is a related party the forgiven debt resulted in an increase to additional paid in capital.   Between January 8, 2017 and August 25, 2017 three shareholders loaned the Company amounts totaling $16,403 in loans bearing 8% interest which have no maturity dates. The loans which accrued interest of $879 were repaid on December 20, 2017. The three debt holders confirmed they were owed no principal or interest as of December 31, 2017.   On December 22, 2017 a loan was made in the amount $2,687 the loan bears no interest and has no maturity date. The loan which accrued interest of $0 was repaid in full on January 8, 2018

Note (8) Subsequent Events   As defined in FASB ASC 855-10, “Subsequent Events”, subsequent events are events or transactions that occur after the balance sheet date but before financial statements are issued or available to be issued.   The Company evaluated all transactions and events that occurred subsequent to the balance sheet date and prior to the date on which the financial statements contained in this report were issued and determined that no such events or transactions necessitated disclosure.

9948077

8591577

100

Following is a table of warrant and options still outstanding and exercisable along with exercise price and range of remaining term.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; line-height: 107%">Type</td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Quantity</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Exercise Price</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Remaining Term</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 45%; line-height: 107%">Warrants Class A</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: right; line-height: 107%">1,000,000</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.50</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: center; line-height: 107%">18 Months</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Warrants Class B</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">1,356,500</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">1.20</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">18-24 Months</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Total</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">2,356,500</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> </table>

The Company had deferred income tax assets as of June 30, 2018 and December 31, 2017 as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%; line-height: 107%">Loss carryforwards</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">84,576</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 14%; text-align: right; line-height: 107%">43,107</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Less- Valuation allowance</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(84,576</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(43,107</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Total net deferred tax assets</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>

7147

2687

850

203

172

800

100

0.90

0.10

6300000

666667

1000000

206000

650000

1150500

0.01

0.075

0.30

0.60

0.01

.60

63000

50000

300000

123600

26000

690300

0.50

1.20

P24M P24M P24M

132458

167542

44454

79146

290996

399304

1.63 0.0168 0.018

All common shares are entitled to one vote per share in all matters submitted to the shareholders.

2356500

1000000

1356500

P18M P18M P24M

402741

123164

2030

84576

43107

84576

43107

2600000

100

800

0.08

5000

16403

879

495000000

9948077

8591577

-15187

-294764

-8980

-188769

-4072

-15187

-7235

-7147

-3665

-301911

-8980

-192434

-4072

-286724

-8980

-185199

-4072

-15187

-7235

Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from two to twenty years.

Basis of Presentation and Organization   The Company was incorporated in 1999 in the state of Utah under the name Datigen.com, Inc. On August 25, 2005, the Company changed its state of incorporation from Utah to Nevada by the merger of the Company with and into its wholly-owned subsidiary, Canna Powder, Inc., a Nevada corporation. As a result of such merger, the Company’s name was changed to Canna Powder, Inc. in order to better reflect the Company’s business operations.   On August 30, 2017, a new wholly-owned subsidiary was registered in Israel under the name of Canna Powder Ltd. (“CannaPowder Israel” or the “Subsidiary”), with 100 common shares outstanding, 0.01 NIS par value (the “Subsidiary Shares”), all of which were held in escrow on behalf of the Company by Israel attorney, Alon Nave. On September 27, 2017, pursuant to board resolution, the 100 Subsidiary Shares held in escrow were transferred to the Company.   On December 27, 2017, a board-resolution was adopted to issue an additional: (i) 800 Subsidiary Shares to the Company; and an additional 100 Subsidiary Shares to Rafi Ezra and, as a result, effective December 27, 2017, Canna Powder Ltd became a 90% owned subsidiary of the Company and a minority interest of 10% owned by Rafi Ezra.   The Subsidiary’s management includes Lavi Krasney, its CEO, and Rafi Ezra, its CTO. Mr. Ezra is a highly experienced pharmacist with extensive knowledge of the cannabis sector and active experience of leading early-stage pharma companies from early-stage development through commercial launch.   Development is being conducted at the Hebrew University pursuant to the term of the Feasibility Study and Option Agreement under the supervision of the inventor of the technology, Professor Shlomo Magdassi.   The Company reasonably expects that the Development Program will be completed within three years, with commercial sales starting in 2021, there can be no assurance that the Development Program will, in fact, be successful notwithstanding the Company’s success in its Equity Raise to date, nor can there be assurance that the Company may not require additional capital to fully implement its business plan and complete production of commercially viable products based on its technology which is the subject of the Feasibility Study discussed below under “Planned Research and Development and Current Trends.”   In the commercial stage, the Company’s plan is to establish and operate several production facilities, each located in separate territories determined by the Company according to their size and regulatory environment that permits studies applicable to other activities prerequisite to commercial exploitation of medical cannabis generally and the Company’s plan to develop cannabis-based powders for medical uses. While there can be no assurance, at present the Company believes that it will be able to produce cannabis powders for medical uses at a significant cost advantage.   The accompanying unaudited financial statements of the Company are presented in accordance with the requirements of Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for an air presentation have been made. The results for these interim periods are not necessarily indicative of the results for the entire year. The accompanying financial statements should be read in conjunction with the Company’s audited financial statements for the year ended December 31, 2017 and the notes thereto included in the Company’s Report on Form 10-K12G filed with the SEC on April 30, 2018.

Cash and Cash Equivalents   For purposes of reporting within the statement of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. As of June 30, 2018, and December 31, 2017, we had cash and cash equivalents of $815,058 and $326,730 respectively.

Reclassifications   Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.

Discontinued Operations   The Company follows the policy of segregating the assets and liabilities of subsidiaries or lines of business on its Balance Sheet from the assets liabilities of continuing subsidiaries or lines of businesses when it is decided to close or dispose of a subsidiary or line of business. The Company also, follows the policy of separately disclosing the assets and liabilities and the net operations of a subsidiary or line of business in its financial statements when it is decided to close or dispose of a subsidiary or line of business.

Revenue Recognition   The Company recognizes revenue ratably over the term of the contract in accordance with ASC 606. In 2018, we are implementing new internal controls as part of our efforts to adopt the new revenue recognition standard. These internal controls include providing global training to our finance team and holding regular meetings with management and the Audit Committee to review and approve key decisions. Upon adoption, we expect to implement new internal controls related to our accounting policies and procedures. We will require new internal controls to address risks associated with applying the five-step model, specifically related to judgments made in connection to variable consideration and applying the constraint. Additionally, we will establish monitoring controls to identify new sales arrangements and changes in our business environment that could impact our current accounting assessment. During the second half of 2018, we expect to finalize our impact assessment and redesign impacted processes, policies and controls.

Loss per Common Share   Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the period. Fully diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

Income Taxes   Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.   The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carryforward period under the Federal tax laws.   Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the realizability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.

Fair Value of Financial Instruments   The Company estimates the fair value of financial instruments using the available market information and valuation methods. Considerable judgment is required in estimating fair value. Accordingly, the estimates of fair value may not be indicative of the amounts the Company could realize in a current market exchange. As of June 30, 2018 and December 31 2017, the carrying value of accounts payable and accrued liabilities approximated fair value due to the short-term nature and maturity of these instruments.

Deferred Offering Costs   The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs are charged against the capital raised. Should the offering be terminated, deferred offering costs are charged to operations during the period in which the offering is terminated.

Impairment of Long-Lived Assets   The Company evaluates the recoverability of long-lived assets and the related estimated remaining lives when events or circumstances lead management to believe that the carrying value of an asset may not be recoverable. As of December 31, 2017, no events or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required.

Estimates   The financial statements are prepared on the basis of accounting principles generally accepted in the United States. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of June 30, 2018 and December 31, 2017, and expenses for the six months ended June 30, 2018 and 2017. Actual results could differ from those estimates made by management.

Impact of Recently Issued Accounting Standards   In June 2018, the FASB issued Accounting Standards Update, or ASU 2018-07, Compensation - Stock Compensation (Topic 718), which simplifies the accounting for non-employee share-based payment transactions. The new standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018 (including interim periods within that fiscal year), with early adoption permitted. The Company adopted the new standard in the second quarter of 2018 and determined that the application of the new standard did not have a material impact on the Company’s unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2018.   In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. Public business entities should apply the amendments in this Update to annual periods beginning after December 15, 2017, including interim periods within those periods. All other entities should apply the amendments to annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019.   In March 2017, the FASB issued Update 2017-08—Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities.For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period.   In March 2017, the FASB issued Update 2017-07—Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. Effective for public business entities for annual periods beginning after December 15, 2017, including interim periods within those annual periods. For other entities, the amendments in this Update are effective for annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. Early adoption is permitted as of the beginning of an annual period for which financial statements (interim or annual) have not been issued or made available for issuance. That is, early adoption should be within the first interim period if an employer issues interim financial statement. Disclosures of the nature of and reason for the change in accounting principle are required in the first interim and annual periods of adoption.

Goodwill and Intangible Assets   Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit.   Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from two to twenty years. No significant residual value is estimated for intangible assets.

20974

11778

9948077

8591577

CAPD Amendment No. 1

0.90

0.10

EX-101.SCH 7 capd-20180630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Prepaid Expenses link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Common Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Prepaid Expenses (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Common Stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Common Stock - Schedule of Warrant and Options Outstanding and Exercisable (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Income Taxes - Schedule of Deferred Income Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 capd-20180630_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 capd-20180630_def.xml XBRL DEFINITION FILE EX-101.LAB 10 capd-20180630_lab.xml XBRL LABEL FILE Legal Entity [Axis] CannaPowder Israel [Member] Title of Individual [Axis] Rafi Ezra [Member] Related Party [Axis] 13 Shareholders [Member] 1 Shareholder [Member] Equity Components [Axis] Class A Warrant [Member] Measurement Input Type [Axis] Volatility [Member] Discount Rate [Member] Range [Axis] Minimum [Member] Maximum [Member] Class B Warrant [Member] Amir Uziel [Member] Attribute Ltd [Member] Lavi Krasney [Member] Kfir Silberman [Member] Debt Instrument [Axis] Notes Payable 1 [Member] Notes Payable 2 [Member] 217 Holders [Member] 189 Holders [Member] Canna Powder Ltd [Member] Rafi Ezra CTO [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Amendment Description Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Prepaid expenses Total current assets Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued liabilities Total current liabilities Notes payable Total long term liabilities Total liabilities Stockholders' equity Common stock, par value $0.00001 per share, 495,000,000 common shares authorized, 5,000,000 preferred shares authorized; 9,948,077 and 8,591,577 shares issued and outstanding at June 30, 2018 and December 31, 2017 respectively. Accumulated other comprehensive income Non-controlling interest Additional paid in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Common stock, par value Common stock, shares authorized Preferred stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Expenses: Research and Development expenses G&A Expenses Total operating expenses (Loss) from operations Other income (expense): Gain (loss) from debt settlement Interest expense Other income (expense) Provision for income taxes Net (loss) Less: loss (income) attributable to noncontrolling Interest Net (loss) attributable to Canna Powder, Inc. Loss per share Weighted average shares outstanding Basic and diluted Statements Of Comprehensive Loss Net loss Change in unrealized foreign currency translation gain (loss) Total comprehensive loss Less: comprehensive loss attributable to non-controlling interest Comprehensive loss attributable to Canna Powder, Inc. Statement of Cash Flows [Abstract] Operating Activities: Net (loss) attributable to Canna Powder, Inc. Non –controlling interest in loss of consolidated subsidiary Adjustments to reconcile net (loss) to net cash (used in) operating activities: Changes in net assets and liabilities: Decrease (increase) in prepaid expenses Decrease (increase) in gain on settlement of notes payable (Decrease) increase in accounts payable Net Cash used in operating activities Financing Activities: Debt and principal payments on debt Issuance of non -convertible notes Proceeds from sale of common stock (net of issuance expenses) Net Cash provided by financing activities FX Adjustment Net increase (decrease) in cash Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period Accounting Policies [Abstract] Summary of Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements [Abstract] Going Concern Prepaid Expenses Prepaid Expenses Equity [Abstract] Common Stock Income Tax Disclosure [Abstract] Income Taxes Related Party Transactions [Abstract] Related Party Transactions Debt Disclosure [Abstract] Notes Payable Subsequent Events [Abstract] Subsequent Events Basis of Presentation and Organization Cash and Cash Equivalents Reclassifications Discontinued Operations Revenue Recognition Loss Per Common Share Income Taxes Fair Value of Financial Instruments Deferred Offering Costs Impairment of Long-Lived Assets Estimates Impact of Recently Issued Accounting Standards Goodwill and Intangible Assets Schedule of Warrant and Options Outstanding and Exercisable Schedule of Deferred Income Tax Assets Statement [Table] Statement [Line Items] Common shares outstanding Common stock par value Subsidiary shares Owned subsidiary percentage Minority interest percentage Intangible assets are amortized period, description Ownership percentage Number of shares sold Sale of stock price per share Total cash consideration Number of shares called by each warrants Warrants exercise price per share Warrants term Fair value of embedded warrants Fair value measurement Common stock shares authorized Common stock voting rights Preferred stock shares issued Preferred stock shares outstanding Warrant outstanding Warrant exercise price Remaining Term Operating loss carryforwards Operating loss carryforwards expiration year Loss carryforwards Less - Valuation allowance Total net deferred tax assets Purchase additional shares Additional shares issued Sales of stock price per share Cash consideration Due to related parties Loan interest rate Accrued interest Number of debt holders Debt instrument borrowed amount Repaid of loan amount Gain on debt extinguishment Prepaid expenses [Text Block] CannaPowder Israel [Member] Rafi Ezra [Member] 13 Shareholders [Member] Class A Warrant [Member] Discount Rate [Member] Class B Warrant [Member] Warrants term. Fair value measurement. Remaining Term. Operating loss carry forwards expiration year. Amir Uziel [Member] Attribute Ltd [Member] Lavi Krasney [Member] Kfir Silberman [Member] Notes Payable 1 [Member] Notes Payable 2 [Member] Number of debt holders. 1 Shareholder [Member] 189 Holders [Member] Canna Powder Ltd [Member] Rafi Ezra CTO [Member] 217 Holders [Member] Assets, Current Assets Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Research and Development Expense General and Administrative Expense Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Net Income (Loss) Attributable to Noncontrolling Interest EX-101.PRE 11 capd-20180630_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2018	Jul. 31, 2018
Document And Entity Information
Entity Registrant Name	CANNAPOWDER, INC.
Entity Central Index Key	0001086082
Document Type	10-Q/A
Document Period End Date	Jun. 30, 2018
Amendment Flag	true
Amendment Description	Amendment No. 1
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		9,948,077
Trading Symbol	CAPD
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2018

XML 13 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 815,058	$ 326,730
Prepaid expenses	25,170	4,196
Total current assets	840,228	330,926
Total assets	840,228	330,926
Current liabilities:
Accounts payable and accrued liabilities	800	800
Total current liabilities	800	800
Notes payable		2,687
Total long term liabilities		2,687
Total liabilities	800	3,487
Stockholders' equity
Common stock, par value $0.00001 per share, 495,000,000 common shares authorized, 5,000,000 preferred shares authorized; 9,948,077 and 8,591,577 shares issued and outstanding at June 30, 2018 and December 31, 2017 respectively.	99	86
Accumulated other comprehensive income	(3,794)	3,353
Non-controlling interest	(15,187)
Additional paid in capital	1,261,051	447,164
Accumulated deficit	(402,741)	(123,164)
Total stockholders' equity	839,428	327,439
Total liabilities and stockholders' equity	$ 840,228	$ 330,926

XML 14 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	495,000,000	495,000,000
Preferred stock, shares authorized	5,000,000	5,000,000
Common stock, shares issued	9,948,077	8,591,577
Common stock, shares outstanding	9,948,077	8,591,577

XML 15 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Revenues
Expenses:
Research and Development expenses	(18,069)		(56,881)
G&A Expenses	(170,700)	3,950	(237,883)	(8,827)
Total operating expenses	(188,769)	(3,950)	(294,764)	(8,827)
(Loss) from operations	(188,769)	(3,950)	(294,764)	(8,827)
Other income (expense):
Gain (loss) from debt settlement		50		50
Interest expense		(172)		(203)
Other income (expense)		(122)		(151)
Provision for income taxes
Net (loss)	(188,769)	(4,072)	(294,764)	(8,980)
Less: loss (income) attributable to noncontrolling Interest	7,235		15,187
Net (loss) attributable to Canna Powder, Inc.	$ (181,534)		$ (279,577)	$ (8,980)
Loss per share	$ (0.02)	$ (0.01)	$ (0.03)	$ (0.01)
Weighted average shares outstanding Basic and diluted	9,549,255	624,910	9,080,605	624,910

XML 16 R5.htm IDEA: XBRL DOCUMENT

Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
Statements of Comprehensive Loss (Unaudited) - USD ($)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Statements Of Comprehensive Loss
Net loss	$ (188,769)	$ (4,072)	$ (294,764)	$ (8,980)
Change in unrealized foreign currency translation gain (loss)	(3,665)		(7,147)
Total comprehensive loss	(192,434)	(4,072)	(301,911)	(8,980)
Less: comprehensive loss attributable to non-controlling interest	7,235		15,187
Comprehensive loss attributable to Canna Powder, Inc.	$ (185,199)	$ (4,072)	$ (286,724)	$ (8,980)

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686

+ Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Operating Activities:
Net (loss) attributable to Canna Powder, Inc.	$ (279,577)	$ (8,980)
Non –controlling interest in loss of consolidated subsidiary	(15,187)
Changes in net assets and liabilities:
Decrease (increase) in prepaid expenses	(20,974)
Decrease (increase) in gain on settlement of notes payable		(50)
(Decrease) increase in accounts payable		(2,748)
Net Cash used in operating activities	(315,738)	(11,778)
Financing Activities:
Debt and principal payments on debt	(2,687)
Issuance of non -convertible notes		11,778
Proceeds from sale of common stock (net of issuance expenses)	813,900
Net Cash provided by financing activities	811,213	11,778
FX Adjustment	(7,147)
Net increase (decrease) in cash	488,328
Cash and cash equivalents - beginning of period	326,730
Cash and cash equivalents - end of period	$ 815,058

XML 18 R7.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

(1) Summary of Significant Accounting Policies

Basis of Presentation and Organization

Cash and Cash Equivalents

Reclassifications

Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.

Discontinued Operations

Revenue Recognition

Loss per Common Share

Income Taxes

Fair Value of Financial Instruments

Deferred Offering Costs

Impairment of Long-Lived Assets

Estimates

Impact of Recently Issued Accounting Standards

Goodwill and Intangible Assets

XML 19 R8.htm IDEA: XBRL DOCUMENT

Going Concern

6 Months Ended

Jun. 30, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Going Concern

Note (2) Going Concern

XML 20 R9.htm IDEA: XBRL DOCUMENT

Prepaid Expenses

6 Months Ended

Jun. 30, 2018

Prepaid Expenses

Prepaid Expenses

Note (3) Prepaid expenses

Prepaid expenses repaid expenses of $25,170 at June 30, 2018 and $4,196 at December 31, 2017, consist of VAT paid to be refunded from the Israel VAT authority.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Common Stock

6 Months Ended

Jun. 30, 2018

Equity [Abstract]

Common Stock

Note (4) Common Stock

On October 17, 2017, the Company sold a total of 6,300,000 shares to 13 shareholders at $0.01 per share for a total cash consideration of $63,000. Four of the shareholders are related parties.

On October 24, 2017 the Company issued 666,667 shares to 1 shareholder at $0.075 per share for cash consideration of $50,000.

Dividends

Securities Authorized for Issuance under Equity Compensation Plans – None.

Following is a table of warrant and options still outstanding and exercisable along with exercise price and range of remaining term.

Type	Quantity		Exercise Price		Remaining Term
Warrants Class A		1,000,000	$	0.50	18 Months
Warrants Class B		1,356,500	$	1.20	18-24 Months
Total		2,356,500

XML 22 R11.htm IDEA: XBRL DOCUMENT

Income Taxes

6 Months Ended

Jun. 30, 2018

Income Tax Disclosure [Abstract]

Income Taxes

Note (5) Income Taxes

The Company had deferred income tax assets as of June 30, 2018 and December 31, 2017 as follows:

	June 30, 2018			2017
Loss carryforwards	$	84,576		$	43,107
Less- Valuation allowance		(84,576	)		(43,107	)
Total net deferred tax assets	$	-		$	-

The Company intends to file income tax returns in the United States. All tax years are closed by expiration of the statute of limitations.

XML 23 R12.htm IDEA: XBRL DOCUMENT

Related Party Transactions

6 Months Ended

Jun. 30, 2018

Related Party Transactions

Note (6) Related Party Transactions

On May 1, 2018 a services agreement was signed with an entity controlled by a related party.

XML 24 R13.htm IDEA: XBRL DOCUMENT

Notes Payable

6 Months Ended

Jun. 30, 2018

Debt Disclosure [Abstract]

Notes Payable

Note (7) Notes Payable

On December 22, 2017 a loan was made in the amount $2,687 the loan bears no interest and has no maturity date. The loan which accrued interest of $0 was repaid in full on January 8, 2018

XML 25 R14.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Jun. 30, 2018

Subsequent Events [Abstract]

Subsequent Events

Note (8) Subsequent Events

XML 26 R15.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)	6 Months Ended
Summary of Significant Accounting Policies (Policies)	Jun. 30, 2018
Accounting Policies [Abstract]
Basis of Presentation and Organization	Basis of Presentation and Organization The Company was incorporated in 1999 in the state of Utah under the name Datigen.com, Inc. On August 25, 2005, the Company changed its state of incorporation from Utah to Nevada by the merger of the Company with and into its wholly-owned subsidiary, Canna Powder, Inc., a Nevada corporation. As a result of such merger, the Company’s name was changed to Canna Powder, Inc. in order to better reflect the Company’s business operations. On August 30, 2017, a new wholly-owned subsidiary was registered in Israel under the name of Canna Powder Ltd. (“CannaPowder Israel” or the “Subsidiary”), with 100 common shares outstanding, 0.01 NIS par value (the “Subsidiary Shares”), all of which were held in escrow on behalf of the Company by Israel attorney, Alon Nave. On September 27, 2017, pursuant to board resolution, the 100 Subsidiary Shares held in escrow were transferred to the Company. On December 27, 2017, a board-resolution was adopted to issue an additional: (i) 800 Subsidiary Shares to the Company; and an additional 100 Subsidiary Shares to Rafi Ezra and, as a result, effective December 27, 2017, Canna Powder Ltd became a 90% owned subsidiary of the Company and a minority interest of 10% owned by Rafi Ezra. The Subsidiary’s management includes Lavi Krasney, its CEO, and Rafi Ezra, its CTO. Mr. Ezra is a highly experienced pharmacist with extensive knowledge of the cannabis sector and active experience of leading early-stage pharma companies from early-stage development through commercial launch. Development is being conducted at the Hebrew University pursuant to the term of the Feasibility Study and Option Agreement under the supervision of the inventor of the technology, Professor Shlomo Magdassi. The Company reasonably expects that the Development Program will be completed within three years, with commercial sales starting in 2021, there can be no assurance that the Development Program will, in fact, be successful notwithstanding the Company’s success in its Equity Raise to date, nor can there be assurance that the Company may not require additional capital to fully implement its business plan and complete production of commercially viable products based on its technology which is the subject of the Feasibility Study discussed below under “Planned Research and Development and Current Trends.” In the commercial stage, the Company’s plan is to establish and operate several production facilities, each located in separate territories determined by the Company according to their size and regulatory environment that permits studies applicable to other activities prerequisite to commercial exploitation of medical cannabis generally and the Company’s plan to develop cannabis-based powders for medical uses. While there can be no assurance, at present the Company believes that it will be able to produce cannabis powders for medical uses at a significant cost advantage. The accompanying unaudited financial statements of the Company are presented in accordance with the requirements of Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for an air presentation have been made. The results for these interim periods are not necessarily indicative of the results for the entire year. The accompanying financial statements should be read in conjunction with the Company’s audited financial statements for the year ended December 31, 2017 and the notes thereto included in the Company’s Report on Form 10-K12G filed with the SEC on April 30, 2018.
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of reporting within the statement of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. As of June 30, 2018, and December 31, 2017, we had cash and cash equivalents of $815,058 and $326,730 respectively.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.
Discontinued Operations	Discontinued Operations The Company follows the policy of segregating the assets and liabilities of subsidiaries or lines of business on its Balance Sheet from the assets liabilities of continuing subsidiaries or lines of businesses when it is decided to close or dispose of a subsidiary or line of business. The Company also, follows the policy of separately disclosing the assets and liabilities and the net operations of a subsidiary or line of business in its financial statements when it is decided to close or dispose of a subsidiary or line of business.
Revenue Recognition	Revenue Recognition The Company recognizes revenue ratably over the term of the contract in accordance with ASC 606. In 2018, we are implementing new internal controls as part of our efforts to adopt the new revenue recognition standard. These internal controls include providing global training to our finance team and holding regular meetings with management and the Audit Committee to review and approve key decisions. Upon adoption, we expect to implement new internal controls related to our accounting policies and procedures. We will require new internal controls to address risks associated with applying the five-step model, specifically related to judgments made in connection to variable consideration and applying the constraint. Additionally, we will establish monitoring controls to identify new sales arrangements and changes in our business environment that could impact our current accounting assessment. During the second half of 2018, we expect to finalize our impact assessment and redesign impacted processes, policies and controls.
Loss Per Common Share	Loss per Common Share Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the period. Fully diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.
Income Taxes	Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences. The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carryforward period under the Federal tax laws. Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the realizability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company estimates the fair value of financial instruments using the available market information and valuation methods. Considerable judgment is required in estimating fair value. Accordingly, the estimates of fair value may not be indicative of the amounts the Company could realize in a current market exchange. As of June 30, 2018 and December 31 2017, the carrying value of accounts payable and accrued liabilities approximated fair value due to the short-term nature and maturity of these instruments.
Deferred Offering Costs	Deferred Offering Costs The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs are charged against the capital raised. Should the offering be terminated, deferred offering costs are charged to operations during the period in which the offering is terminated.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company evaluates the recoverability of long-lived assets and the related estimated remaining lives when events or circumstances lead management to believe that the carrying value of an asset may not be recoverable. As of December 31, 2017, no events or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required.
Estimates	Estimates The financial statements are prepared on the basis of accounting principles generally accepted in the United States. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of June 30, 2018 and December 31, 2017, and expenses for the six months ended June 30, 2018 and 2017. Actual results could differ from those estimates made by management.
Impact of Recently Issued Accounting Standards	Impact of Recently Issued Accounting Standards In June 2018, the FASB issued Accounting Standards Update, or ASU 2018-07, Compensation - Stock Compensation (Topic 718), which simplifies the accounting for non-employee share-based payment transactions. The new standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018 (including interim periods within that fiscal year), with early adoption permitted. The Company adopted the new standard in the second quarter of 2018 and determined that the application of the new standard did not have a material impact on the Company’s unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2018. In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. Public business entities should apply the amendments in this Update to annual periods beginning after December 15, 2017, including interim periods within those periods. All other entities should apply the amendments to annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. In March 2017, the FASB issued Update 2017-08—Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities.For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. In March 2017, the FASB issued Update 2017-07—Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. Effective for public business entities for annual periods beginning after December 15, 2017, including interim periods within those annual periods. For other entities, the amendments in this Update are effective for annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. Early adoption is permitted as of the beginning of an annual period for which financial statements (interim or annual) have not been issued or made available for issuance. That is, early adoption should be within the first interim period if an employer issues interim financial statement. Disclosures of the nature of and reason for the change in accounting principle are required in the first interim and annual periods of adoption.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from two to twenty years. No significant residual value is estimated for intangible assets.

XML 27 R16.htm IDEA: XBRL DOCUMENT

Common Stock (Tables)

6 Months Ended

Jun. 30, 2018

Equity [Abstract]

Schedule of Warrant and Options Outstanding and Exercisable

Following is a table of warrant and options still outstanding and exercisable along with exercise price and range of remaining term.

Type	Quantity		Exercise Price		Remaining Term
Warrants Class A		1,000,000	$	0.50	18 Months
Warrants Class B		1,356,500	$	1.20	18-24 Months
Total		2,356,500

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

XML 28 R17.htm IDEA: XBRL DOCUMENT

Income Taxes (Tables)

6 Months Ended

Jun. 30, 2018

Income Tax Disclosure [Abstract]

Schedule of Deferred Income Tax Assets

The Company had deferred income tax assets as of June 30, 2018 and December 31, 2017 as follows:

	June 30, 2018			2017
Loss carryforwards	$	84,576		$	43,107
Less- Valuation allowance		(84,576	)		(43,107	)
Total net deferred tax assets	$	-		$	-

XML 29 R18.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative) - USD ($)			6 Months Ended
	Dec. 27, 2017	Sep. 27, 2017	Jun. 30, 2018	Dec. 31, 2017	Aug. 30, 2017	Jun. 30, 2017	Dec. 31, 2016
Common shares outstanding			9,948,077	8,591,577
Common stock par value			$ 0.00001	$ 0.00001
Subsidiary shares	800
Owned subsidiary percentage	90.00%
Cash and cash equivalents			$ 815,058	$ 326,730
Intangible assets are amortized period, description			Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from two to twenty years.
Rafi Ezra [Member]
Subsidiary shares	100
Minority interest percentage	10.00%
CannaPowder Israel [Member]
Common shares outstanding					100
Common stock par value					$ 0.01
Subsidiary shares		100

XML 30 R19.htm IDEA: XBRL DOCUMENT

Going Concern (Details Narrative)	Aug. 30, 2017
Rafi Ezra CTO [Member]
Ownership percentage	10.00%
Canna Powder Ltd [Member]
Ownership percentage	90.00%

XML 31 R20.htm IDEA: XBRL DOCUMENT

Prepaid Expenses (Details Narrative) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Prepaid Expenses
Prepaid expenses	$ 25,170	$ 4,196

XML 32 R21.htm IDEA: XBRL DOCUMENT

Common Stock (Details Narrative) - USD ($)					1 Months Ended		6 Months Ended
Common Stock (Details Narrative) - USD ($)	Mar. 29, 2018	Dec. 07, 2017	Oct. 24, 2017	Oct. 17, 2017	May 14, 2018	Dec. 07, 2017	Jun. 30, 2018	Dec. 31, 2017
Number of shares sold	206,000				1,150,500	1,000,000
Sale of stock price per share	$ 0.60	$ 0.30			$ .60	$ 0.30
Total cash consideration	$ 123,600				$ 690,300	$ 300,000
Number of shares called by each warrants	1	1			1	1
Fair value of embedded warrants	$ 44,454				$ 290,996	$ 132,458
Common stock shares authorized							495,000,000	495,000,000
Common stock par value							$ 0.00001	$ 0.00001
Common stock voting rights							All common shares are entitled to one vote per share in all matters submitted to the shareholders.
Volatility [Member]
Fair value measurement		163.00%				163.00%
Discount Rate [Member] \| Minimum [Member]
Fair value measurement		1.68%				1.68%
Discount Rate [Member] \| Maximum [Member]
Fair value measurement		1.80%				1.80%
Class A Warrant [Member]
Number of shares called by each warrants		1				1
Warrants exercise price per share		$ 0.50				$ 0.50	$ 0.50
Warrants term		24 months
Fair value of embedded warrants		$ 167,542
Class B Warrant [Member]
Number of shares called by each warrants	1				1
Warrants exercise price per share	$ 1.20				$ 1.20		$ 1.20
Warrants term	24 months				24 months
Fair value of embedded warrants	$ 79,146				$ 399,304
13 Shareholders [Member]
Number of shares sold				6,300,000
Sale of stock price per share				$ 0.01
Total cash consideration				$ 63,000
1 Shareholder [Member]
Number of shares sold			666,667
Sale of stock price per share			$ 0.075
Total cash consideration			$ 50,000
217 Holders [Member]
Common stock shares authorized							9,948,077
Common stock par value							$ 0.00001
Preferred stock shares issued
Preferred stock shares outstanding
189 Holders [Member]
Common stock shares authorized								8,591,577
Common stock par value								$ 0.00001
Preferred stock shares issued
Preferred stock shares outstanding

XML 33 R22.htm IDEA: XBRL DOCUMENT

Common Stock - Schedule of Warrant and Options Outstanding and Exercisable (Details) - $ / shares	6 Months Ended
	Jun. 30, 2018	May 14, 2018	Mar. 29, 2018	Dec. 07, 2017
Warrant outstanding	2,356,500
Class A Warrant [Member]
Warrant outstanding	1,000,000
Warrant exercise price	$ 0.50			$ 0.50
Remaining Term	18 months
Class B Warrant [Member]
Warrant outstanding	1,356,500
Warrant exercise price	$ 1.20	$ 1.20	$ 1.20
Class B Warrant [Member] \| Minimum [Member]
Remaining Term	18 months
Class B Warrant [Member] \| Maximum [Member]
Remaining Term	24 months

XML 34 R23.htm IDEA: XBRL DOCUMENT

Income Taxes (Details Narrative) - USD ($)	6 Months Ended
Income Taxes (Details Narrative) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Operating loss carryforwards	$ 402,741	$ 123,164
Operating loss carryforwards expiration year	2030

XML 35 R24.htm IDEA: XBRL DOCUMENT

Income Taxes - Schedule of Deferred Income Tax Assets (Details) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Loss carryforwards	$ 84,576	$ 43,107
Less - Valuation allowance	(84,576)	(43,107)
Total net deferred tax assets

XML 36 R25.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Details Narrative)			1 Months Ended		8 Months Ended	12 Months Ended
Related Party Transactions (Details Narrative)	Mar. 29, 2018 USD ($) $ / shares shares	Oct. 17, 2017 USD ($) $ / shares shares	May 14, 2018 USD ($) $ / shares shares	Dec. 07, 2017 USD ($) $ / shares shares	Aug. 25, 2017 USD ($)	Dec. 31, 2017 Integer	Jan. 08, 2018 USD ($)	Dec. 20, 2017 USD ($)	May 12, 2016 USD ($)
Purchase additional shares	206,000		1,150,500	1,000,000
Sales of stock price per share \| $ / shares	$ 0.60		$ .60	$ 0.30
Cash consideration \| $	$ 123,600		$ 690,300	$ 300,000
Due to related parties \| $					$ 16,403				$ 5,000
Loan interest rate					8.00%	8.00%
Accrued interest \| $							$ 0	$ 879
Number of debt holders \| Integer						3
Amir Uziel [Member]
Purchase additional shares		650,000
Additional shares issued		2,600,000
Sales of stock price per share \| $ / shares		$ 0.01
Cash consideration \| $		$ 26,000
Attribute Ltd [Member]
Purchase additional shares		650,000
Additional shares issued		2,600,000
Sales of stock price per share \| $ / shares		$ 0.01
Cash consideration \| $		$ 26,000
Lavi Krasney [Member]
Purchase additional shares		650,000
Additional shares issued		2,600,000
Sales of stock price per share \| $ / shares		$ 0.01
Cash consideration \| $		$ 26,000
Kfir Silberman [Member]
Purchase additional shares		650,000
Additional shares issued		2,600,000
Sales of stock price per share \| $ / shares		$ 0.01
Cash consideration \| $		$ 26,000

XML 37 R26.htm IDEA: XBRL DOCUMENT

Notes Payable (Details Narrative)		3 Months Ended		6 Months Ended		8 Months Ended	12 Months Ended
Notes Payable (Details Narrative)	May 05, 2017 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2017 USD ($)	Aug. 25, 2017 USD ($)	Dec. 31, 2017 USD ($) Integer	Jan. 08, 2018 USD ($)	Dec. 22, 2017 USD ($)	Dec. 20, 2017 USD ($)	May 12, 2016 USD ($)
Loan interest rate						8.00%	8.00%
Repaid of loan amount	$ 850			$ 2,687
Gain on debt extinguishment	$ 50		$ 50		$ 50
Due to related parties						$ 16,403					$ 5,000
Accrued interest								$ 0		$ 879
Number of debt holders \| Integer							3
Notes payable							$ 2,687		$ 2,687
Notes Payable 1 [Member]
Debt instrument borrowed amount							100
Notes Payable 2 [Member]
Debt instrument borrowed amount							$ 800

EXCEL 38 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( !5^"4T?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ %7X)36;S"V"" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGB06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " 5?@E-5GL0F/ K @ $0 &1O8U!R;W!S+V-O M&ULS9+;2@,Q$(9?17*_.[L]J W;O;%XI2!84+P+R;0-;@XD([M]>[.Q MW2+Z (7<9.;/-]] &NFY= %?@O,82&.\&4QG(Y=^S0Y$G@-$>4 C8ID2-C5W M+AA!Z1KVX(7\%'N$657=@D$22I" $5CXBDUKUMH&TE8B>E5U)R.'M?L//EM_K#9/K)V5M7W197.:ELO^>*.+U&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&V MM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X M>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E M'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ( MX53"Q,!J9S]6:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T M;1K@X_%X.+;+THMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW? MZYMHG J-6T_3:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;C MZWH2%;7E0-,@ %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6 M-$9RG9 %#@ WQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[ MR:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>I MP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^ M",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ M ?_1VC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH M9%LE"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-# MMW)+ZK:4OK4F.$KTL@'37[]EUVY".E,%.70[@:0KX# M;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW' MB/*B(>ZAAIC/PT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$" M\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO* MWF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4" M(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8> M^3+?.7#;.MX#7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@ M#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6: M&C/5BZPYC0IO0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+ MOP%02P,$% @ %7X)3>FE)?UR @ >@@ !@ !X;"]W;W)KSP4/1>OLJ)4>6\-:^76KY3JGH- GBO:$/G$.]KJ ME2L7#5%Z*&Z![ 0E%TMJ6(##, T:4K=^6=BYHR@+?E>L;NE1>/+>-$3\WE/& M^ZV/_/>)E_I6*3,1E$5';O0;5=^[H]"C8+)RJ1O:RIJWGJ#7K;]#SP>4&()% M_*AI+V=]SX1RXOS5##Y?MGYH/**,GI4Q073SH ?*F+&D_?@U&O4G34.<]]^M M?[3!ZV!.1-(#9S_KBZJV?NY[%WHE=Z9>>/^)C@$EOC=&_X4^*--PXXG6.',F M[=<[WZ7BS6A%N]*0MZ&M6]OVPTJ,1AI,P",!3P2<_I<0C81H(J#8!C]X9D/] M0!0I"\%[3PRGU1%S*=!SI#?S;";MWMDU':W4LX\R+(*',3,B]@,"SQ!H0@3: M]B2 (8$]=NCX7X&#BXA@@0B,(++T:$:/87H,TF-+CV?T9+$!+B*%!1)0(''H MV4)@0"06T0X['.9IF&-8)@5E4D9FL!P8F,(E<*+0,","MI@N!\1VXZXVBI,F#2 M.6;E44%PTB,WZ_'R74%NWN-P=H2#3C![R1LJ;K;H2>_,[ZVMN+/9J;#NL*T$ M?^%#5?Y*Q*UNI7?B2M<3^^I?.5=4.Q,^:3E"^Y[QU-V..JVPULMJO0@?TK]7#W6IN6-H^RR0I9- MIDJGEONE^PD>-LQO#9WB5R8OS>3<:4MY4>JU;7S;+5V_)9*YW.IVB-0TD1N5_\YV^KAT8]?9R7UZRO63NGR5 M0T&!ZPS5?Y=GF1MY2V+FV*J\Z7Z=[:G1JAA&,2A%^M8?L[([7H;QWVVT@0T& M-AI W#3PP< M@]>3=:5^3G6Z6M3JXM3]W:K2=E' S<7<]MV=M>N^\]4VYC> M\XJ%"^_-IT-R^182(BUD8.BJ!HV4OYFXS M'6^ \TW8H0(XNI+$K@9KXID'&.AT QQOP@X4P,%UQZ-$V#!4O@4S>0!TO '. M-\%M')Q<=Q! C-8=D95S-YJ.-X@PC9U/@V9* RP$/P ;!PN%B" 4,TAT8@*. M3&%'%> \O#-O@,A>8AM*"(S/,]'I"3@^!0HM(AMY(M!;B=!Q0SYYV*_W0G2, M,AR1PEH>ZT%SM9VAWI.$CGQ1>I/M8KM__Y'6AZQLG!>ES&PO=V]R:W-H965T&ULC97;CILP M$(9?!7'?-2>') *D)E752JT4;;7MM0-#0&LPM9VP??O:AD4$W.YR@4__/_,- M8)/TC#^+"D Z+PUM1>I64G9[A$1>04/$ ^N@52LEXPV1:L@O2'0<2&%,#46! MYVU00^K6S1(S=^)9PJZ2UBVN[[Y./-:72NH)E"4=N< / MD$_=B:L1FJ(4=0.MJ%GK<"A3]Z._/\9:;P0_:^C%K._H2LZ,/>O!UR)U/0T$ M%'*I(Q#5W. (E.I "N/W&-.=4FKCO/\:_;.I7=5R)@*.C/ZJ"UFE[M9U"BC) ME'"@ 8R4^HG(DF6<-8[?'A9'='?A+\/UQ$;^ON>#96GLV:)USP;%9Y=KMHZ\7Q@F>MV^*=C^-_?'^Q ME2=>\T0+GOB=/&N=G0?--J@^,+\3?JE;X9R95'O=[,B2,0DJIO>@PE7JC)X& M%$JIN['J\^&D&@:2=>,AC*8_0?874$L#!!0 ( !5^"4W=80&'I , !D1 M 8 >&PO=V]R:W-H965T&ULC9A?DYHP%,6_"L-[ER00 M$G;4F47MM#/MS$X[;9]9CI8JF3;%N69QP@) MO3Q)"WR\5,G^HL+=1SZ52G/$_*?['*]'GN4O>MX5NZ/]1-@[>8'9.] M^J[J'\?GTIQY%Y=MFJNB2G7AE&HW=Y_HXYI&34&K^)FJ? MMW.7-"-2F=K4C45BOE[54F59XV3&\:G_Z)>56;DS4A,'QN=5>VGLSE5MP2X'I^UJ!WQ?X[P7!U8*@+PCN[8'W!=SJP>O8 MV\E<)76RF)7Z[)3=]7!,FLN./G*S7)NFL5V=]C&Y]>$G<2 M-I2$8\D*2NA%X9G^+X-@V"!B!LK9N(,E5'!AC>&FR?JJR6B8/CI7?EOO#^LE M7A^@]4%;'PSK(VNNH<2W.)>W):O;DO55R8B%HRPXNA.-D2'L"$JE W13;-1@C_?";Q1^83#1$)0.#_6\S]&-."YU6N& M.&!F[O!97_<9$Z%Q\T09)!(V$=1 (H;=SH\'2B/J22-A74 M0"H?H6* ZK;3&G7B$V\&%,],"H/*ONMB1 .I[HC-.S3KZYHQ$9ZZ+C7B/'"4>X'-ADT@V2(&1,1%X -$5Y9-3SB*7FVYC.CSD*4QY8:<\A8$;\2!B]HYHB0A#%D04Q!EB M2,PK+.$VXDW#CM$;;.MR5>[;/7;E;/2IJ)N0'[1>]O%/K-D66NTQ?5Q2I'W5 M[/O;;>2[??>GP=>DW*=%Y;SHVFQ&VRWC3NM:F>&3!S/P@TJVEY-,[>KF4)CC MLMNL=R>U/O9_1'B7?T,6_P%02P,$% @ %7X)38LMKXF> @ \ @ !@ M !X;"]W;W)K%ZSGGWL-587%E_$6<*)7!:U.W M8AF>I.SF423*$VV(>& =;=63 ^,-D6K*CY'H."5[0VKJ",8QBAI2M>%J86)/ M?+5@9UE7+7WB@3@W#>&_"UJSZS($X5O@N3J>I Y$JT5'CO0;E=^[)ZYFT:BR MKQK:BHJU :>'9?@(YMMJ-?=K_P2A@>8GP($ M1X+*?8^0#(3DG9#>):0#(?W?#-E R*P,4>_=+.:&2+):<'8->/\Z=$2_=6"> MJ7:5.FBZ8YZI]10J>EGA;!%=M,X *7H(G$ R= O9N! P(B*5?RP"^HHHH$.' MMPG6+B+#5@W_%-G>%;DI,_&N56+XR72MD)^?>OFIX:=3OF6BZ"'80%H#^0#R M'*.9M1X>7!ICR_#&@X*S%*/46A@/+I_EL=];YO66N=YRRUL/R:99$H2LMVWM M"B5VISU"&*06:GM7Z,81\CI"KB.K"P5R"P$SF";6^JX].$^W/*@D!C, +&,> MW-^[A;W>L.-MPN^]82<+AHG=+%?':9:K S*0V\VZ*W1C*/<:REU#UK(5N>_3 MRL#,_K0\.$^S/"B8(PSM3\N#\S0KFORN&\J/9N\402=&PO=V]R:W-H965T&ULC59A;YLP$/TKB.\KG W8 MKI)(3:9IDS:IVK3M,TV996W=^HD:_-FKYHJUV;9'*+VU,A\9X.J,B)QG$55 M7M3A:F'W'IO50IUU6=3RL0G:Z2Y&;VT5N9%EVF0R//T/2<*S9!4Z?7[-_LN*-F*>\E1M5_BYV^K@, M>1CLY#X_E_J[NGZ6@Z T# ;U7^5%E@;>,3$UMJIL[378GENMJB&+H5+E+_V] MJ.W]VK_)R!#F#R!# !D#3.U; 70(H&\!B17?,[-2/^8Z7RT:=0V:_FN=\NY0 MP#TUS=QVF[9W]IU1VYK=RXJ3173I\@R0=0\A$PB,B,@D'RL07X4U0>%.@0U& MI,Q?@7HU4!M/IQJH/S[QQB M-BEBPQ.'30])IU4@!>Z2P9GH3%\S+Y,,]S7UQS-O/,-*,D<)PTI(+)@C>(,S MS2GA7B8<,W&:M<80ZO:38[+IS*<57AH"T^ .#0Q!-(2G9RSA?B(0^W_[&%,1 M[G\?XT(44D8=SAL?$("Q.4HS3@3HN(F9[H+7:1Z (%$"7%'$T[T,_3J>5',G M#ORF!!230AK#Y@IX5N]]3L<8(L3U"63H$( M3309D2K9'.PTV09;=:YU-XU,=L>)]<$.<<[^NIMD[>CUEJ8?@[_ES:&HV^!) M:3/ V3%KKY26AF)\9UIZ-)/WN"CE7G>/S#PW_?C9+[0Z#:-U-,[WJW]02P,$ M% @ %7X)388#(6>U 0 T , !@ !X;"]W;W)K).^9%K*G91Y]9UOF9O1*]G"VQ(U:"_O[!,I,!4WIJ^-1MIT/ M#E;F@VCA._@?P]FBQ5:56FKHG30]L= 4]#X]GK* CX G"9/;G$FHY&+,!VA0=0*@AA&K\63;J&#,3M^57]4ZP=:[D(!P]&_92U[PIZ M2TD-C1B5?S339UCJ>4?)4OQ7N()">,@$8U1&N;B2:G3>Z$4%4]'B9=YE'_=I MOLD."VV?P!<"7PFW,0Z; \7,/PHORMR:B=BY]X,(3YP>.?:F"L[8BGB'R3OT M7LN[NYQ=@\X".,L.5*9L8]SO/&NXWK/XXO\A<^S_DW85O:.7(S' M=XW=;XSQ@*DD-SA '7ZOU5#0^'#\@&<[#]EL>#,L_X>MG[C\ U!+ P04 M" 5?@E-!M?M-Z\! #2 P & 'AL+W=O= *G7:>JD33IUVOHY!P:B)I@FX>C^_9+ 4=:A M?2&V\7M^=IQL1/-L6P!'7K7J;$Y;Y_H#8[9L00M[@SUT_D^-1@OG7=,PVQL0 M501IQ7B2W#(M9$>++,9.ILAP<$IV<#+$#EH+\_L("L><[N@U\"B;UH4 *[)> M-/ #W,_^9+S'%I9*:NBLQ(X8J'-ZMSLU J$'D9+S,G74H&X-J^LG^)O?M>SL+"/:HG6;DVIY\HJ: 6 M@W*/.#[ W,\'2N;FO\$%E$\/2GR-$I6-7U(.UJ&>6;P4+5ZG4W;Q'&?^*VP; MP&< ?P=@4Z&H_+-PHL@,CL1,L^]%N.+=@?O9E"$81Q'_>?'61R_%+N$9NP2B M.>V. IJ%\R/WC;3FDV.PWY^06QYQL4?4$L#!!0 ( !5^"4WTH^@8 MLP$ -(# 8 >&PO=V]R:W-H965T&UL?5/;;MP@$/T5 MQ <$+[NY:&5;RJ:J4JF55JG:/+/VV$;AX@!>IW]?P,1Q6BU#^IM%&,N=-TQ+;&V!U!$E!:)9=$?4=3YGIP@BLX&F0'*9GY="PY2YCUKX2>X7_W1>(O, M+#67H"S7"AEH"GR[V1]V(3X&_.8PVL49A4I.6C\%XUM=X"P( @&5"PS,;V>X M R$"D9?QG#CQG#( E^=7]J^Q=E_+B5FXT^*1UZXK\ U&-31L$.Y!C_>0ZKG$ M*!7_'<4="W%@?X'I^OP[:K";81O/U#XCF"W2K"+!+M/2UR+N?HG"5GT5()I MXS195.E!Q4E>>.>!O:7Q3=["IVG_P4S+E44G[?S+QOXW6COP4K(+/T*=_V"S M(:!QX7CMSV8:L\EPND\_B,S?N/P+4$L#!!0 ( !5^"4TX:PZ)M $ -(# M 9 >&PO=V]R:W-H965T29M<0%FF'/FS##DHS;/M@-P MZ$4*90O<.=--I(Y;YJ6V-X JR-("D*S[)I(QA4N\^@[ MF3+7@Q-(-?'0^\[5QPD#+O60L_P?WJ3\9;9&:IN01E MN5;(0%/@V\WAN OQ,>"1PV@79Q0J.6O]'(QO=8&S( @$5"XP,+]=X Z$"$1> MQN_$B>>4 ;@\O[+?Q]I]+6=FX4Z+)UZ[KL![C&IHV"#<@QZ_0JKG$T:I^.]P M >'#@Q*?H]+"QA55@W5:)A8O1;*7:>D1FZGW/PA-O#M3WI@K.V(IXY\5;[[V4F^PF)Y= E&*.4PQ=QLP1Q+// M*>A:BB-]!Z?K\.VJPFV$;_]1N%\GV*T2["+![L,2UV(^_Y>$+'HJP;1QFBRJ M]*#B)"^\\\#>TO@F;^'3M/]@IN7*HK-V_F5C_QNM'7@IV94?H&UL?5/MCM4@$'T5P@,L_;CJYJ9M MLG>-T423FS7J;VX[;KF\OT&ZMVMT_P QSSIP9AF)"\VA[ $>>E-2V MI+USPY$Q6_>@N+W! ;2_:=$H[KQI.F8' [R)("59EB1OF>)"TZJ(OK.I"AR= M%!K.AMA1*6Y^G4#B5-*4/CL>1->[X&!5,? .OH+[-IR-M]C*T@@%V@K4Q$!; MTKOT>#J$^!CP7Y0_1N+ZDMY0TT/)1N@>GC@]9KXW=7#&5L0[+]YZ[[5*TZ1@UT"TQ)SFF&P;LT8PS[ZFR/92 MG++_X-D^/-]5F$=X_I?"%_(?=@D.D>#P:HE[,?^J9)N>*C!=G"9+:AQUG.2- M=QW8NRR^R9_P>=J_<-,);K]!UL-":T+QW?^;.8Q MFPV'P_*#V/J-J]]02P,$% @ %7X)35]VE:&T 0 T@, !D !X;"]W M;W)K&UL?5-MC]0@$/XKA!]P;%].-YNVR>T9HXDF MFS/J9[:=MN2 J4"WY[\7:*]6;?P"S##/,\\,0S&A>;8]@",O2FI;TMZYX<28 MK7M0W-[A -K?M&@4=]XT';.# =Y$D)(L/1S>,,6%IE41?1=3%3@Z*31<#+&C M4MS\/(/$J:0)?74\B:YWP<&J8N =? 'W=;@8;[&5I1$*M!6HB8&VI _)Z9R' M^!CP3-TL:5 MU*-UJ!86+T7QEWD7.N[3?),=%]@^(%T Z0HXQCQL3A25O^..5X7!B9BY]P,/ M3YR<4M^;.CAC*^*=%V^]]U8E25:P6R!:8LYS3+J-62.89U]3I'LISND_\'0? MGNTJS"(\^T-AOD^0[Q+DD2#_;XE[,?=_)6&;GBHP79PF2VH<=9SDC7<=V(_ %!+ P04 " 5?@E-JG\-OK0! #2 P &0 'AL+W=O9NQ%$BF>PT.*2@=C7UP#X,F;DMIEM/&^.S+FB@:4 M<#>F XTWE;%*>#1MS5QG0901I"3CF\TM4Z+5-$^C[VSSU/1>MAK.EKA>*6%_ MG4":(:,)_7 \MG7C@X/E:2=J> +_HSM;M-C,4K8*M&N-)A:JC-XEQ],NQ,> MGRT,;G$FH9*+,2_!^%IF=!,$@83"!P:!VQ7N0)TXZIPS Y?F#_4NL M'6NY" ?W1CZWI6\R>J"DA$KTTC^:X0&F>CY1,A7_#:X@,3PHP1R%D2ZNI.B= M-VIB02E*O(U[J^,^C#=\/\'6 7P"\!EPB'G8F"@J_RR\R%-K!F+'WG9)<4?"W%B?\#Y^OP[:K" M;81O_U"X7R?8K1+L(L'NOR6NQ1S^2L(6/55@ZSA-CA2FUW&2%]YY8.]X?)/? MX>.T?Q>V;K4C%^/Q96/_*V,\H)3-#8Y0@Q]L-B14/ASW>+;CF(V&-]WT@]C\ MC?-W4$L#!!0 ( !5^"4W6]MN4M $ -(# 9 >&PO=V]R:W-H965T M++/I.MLC,X)7LX&2)&[06]N\1E!ES MFM)7QZ-L6A\@_&MRFD2$@(%I0\* K<+W(-200C3^#-KTB5D(*[/K^I?8NU8RUDX MN#?J25:^S>D-)1748E#^T8Q?8:[GFI*Y^.]P 87PD G&*(UR<27EX+S1LPJF MHL7+M,LN[N-TPV]GVC:!SP2^$&YB'#8%BID_""^*S)J1V*GWO0A/G!XX]J8, MSMB*>(?)._1>BC2]S=@E",V8XX3A:\R"8*B^A.!;(8[\'9UOTW>;&>XB?;>. MSI-M@?VFP#X*[#\L<0/#WQ;)5CW58)LX38Z49NCB)*^\R\#>\?@F_^'3M/\0 MMI&=(V?C\65C_VMC/& JR16.4(L?;#$4U#X&UL=5;;CILP$/T5Q >LL;F$1 0IV:IJI5:*MNKVV2%.0&LPM9VP M_?O:AJ44AA=\X:-VONEUNT.(564K*;J2;2L,7^N M0M94FZ&\(=5*1B_.J.:(!$&":EHU?IZYN9/,,W'7O&K827KJ7M=4_CDR+KJ] MC_V/B9?J5FH[@?*LI3?V@^F?[4F:$1I9+E7-&E6)QI/LNO'?$B35PB->* M=6K2]VPH9R'>[.#K9>\'UB/&6:$M!37-@STSSBV3\>/W0.J/FM9PVO]@_^R" M-\&]]6C6N[_D\<#6:P 1D,R&B0.AW4"SG//U%-\TR*SI/]XK?4 M[C'>$;,VA9UT2^'^&>>5F7WDF) ,/2S1@#GV&#+%C ADV$<) DDA# !!%($#F"Z+\0PUF($":"16)0) 8(XID(A$E@D00420""S4P$ MPJ2PR 84V0 $VYD(@ E7]B0%15* ,]$(,S*R=F"(EN 8+[Q$&9EXW$ 9U"P MI,#!/(4 4!BOZ*QD*@8HDKD.!-JLZ(#I>L $H$CG.A!HNZ(#YS4.EQ318MT@ MT,KM@^'TQT!N1XLK#@*%*SKP#8"!](ZBN0X$6CL'\"6 @0R/%N< LW/ 9H4 MB9K)FRN/RBO$O7&U>3([EN #<47F'[ROW]^IO%6-\LY"FU+E"LI5",V,+\&3 MB;DT3X9QP-E5V^[&]&5?-_N!%NWP)D#CPR3_"U!+ P04 " 5?@E-QT<* MP[552VX)VSO5'QFS5@>+V#GO0_J9!H[CSIFF9[0WP.I*49&F2/##% MA:9E'GUG4^8X."DTG VQ@U+<_#Z!Q+&@.WIS/(NV<\'!RKSG+7P#][T_&V^Q M1:46"K05J(F!IJ"/N^,I"_@(^"%@M*LS"95<$%^"\;DN:!(2 @F5"PK<;U=X M BF#D$_CUZQ)EY"!N#[?U#_&VGTM%V[A">5/4;NNH =*:FCX(-TSCI]@KN>> MDKGX+W %Z>$A$Q^C0FGC2JK!.E2SBD]%\==I%SKNXW3S<*-M$]*9D"Z$0R2P M*5#,_ -WO,P-CL1,O>]Y>.+=,?6]J8(SMB+>^>2M]U[+77;(V34(S9C3A$G7 MF 7!O/H2(MT*<4K_HZ?;]/UFAOM(WZ^C)X=M@6Q3((L"V3\EOG]3X@;F/GD3 MA*UZJL"T<9HLJ7#0<9)7WF5@']/X)G_AT[1_Y:85VI(+.O^RL?\-H@.?2G+G M1ZCS'VPQ)#0N'-_YLYG&;#(<]O,/8LLW+O\ 4$L#!!0 ( !5^"4T+CV[1 MMP$ -(# 9 >&PO=V]R:W-H965T- VSO0%119!6C.]V'Y@6 MLJ-%%GTG4V0X."4[.!EB!ZV%>3V"PC&G"7US/,FF=<'!BJP7#7P#][T_&6^Q MA:62&CHKL2,&ZIS>)8?C/L3'@!\21KLZDU#)&?$Y&%^KG.Y"0J"@=(%!^.T" M]Z!4(/)I_)HYZ2(9@.OS&_OG6+NOY2PLW*/Z*2O7YO26D@IJ,2CWA.,7F.NY MIF0N_@$NH'QXR,1KE*AL7$DY6(=Z9O&I:/$R[;*+^SC=I!]GV#: SP"^ &ZC M#IN$8N:?A!-%9G D9NI]+$3)P?N>U,&9VQ%O//)6^^]%,EUDK%+()ICCE,, M7\E:/?F/_GZ38!$]G^5R-^5N!63OA-A MJYYJ,$V<)DM*'+HXR2OO,K!W/+[)G_!IVA^%:61GR1F=?]G8_QK1@4]E=^5' MJ/4?;#$4U"X<;_S93&,V&0[[^0>QY1L7OP%02P,$% @ %7X)30&($AJM M @ 6@H !D !X;"]W;W)K&ULC59;;YLP%/XK MB/<5FSM1$FE-FW;2)E6MMCV[B9.@ F:VDW3_?C:X",RAXR78YKN<8Y\TL+=EVYV/U8>,Z/)ZD7O/6R)D?Z M0N7/^HFKF=>I[/.25B)GE5^Q8M''&I"@_B5TZOHC1V=RBMC;WKR;;]R MD8Z(%G0GM011CPO=T*+02BJ./T;4[3PUL3_^4-\VR:MD7HF@&U;\SO?RM')3 MU]G3 SD7\IE='ZE)*'(=D_UW>J&%@NM(E,>.%:+Y=79G(5EI5%0H)7EOGWG5 M/*_MFR0P-)C@&X+?$=K-F20$AA#,)82&$':$%'U*B PAFNL0&T(\EY 80C*7 MD!I":A&\]CB:\[TCDJR7G%T=WI9H3?0_ 2]254$[O=@43/-.';%0JY)&O/VMM-.)*O-3<[KKI/K M?U!+ P04 " 5?@E-YC-1DJL! ! &0 'AL+W=O^&':9G9D%;S%J\V8[ $?>E>QM23OGAAUCMNY <7NC!^CQ MI-5&<8>A.3$[&.!-*%*294FR88J+GE9%R!U,5>BSDZ*'@R'VK!0W'WN0>BQI M2C\3S^+4.9]@53'P$_P&]S(<#$9L86F$@MX*W1,#;4GOTMT^]_@ >!4PVJL] M\9TX!RD]$=KX.W/21=(77N\_V1]#[]C+D5NX MU_*/:%Q7TEM*&FCY6;IG/?Z N9^>R>$$V%V1+01H*V"04G#]PQZO"Z)&8Z>X'[I\XW65X-[5/ MAJL(9VC>8O92I=ND8!=/-&/V$R:[QN3;!<.0?Q')HB)9(%C_)Y+&"591@E6$ M(/OB,H+9W,9%UE&1=41D%2?(HP3Y-UQ&,)NO(NSJ\?QL/'%S$KTE1^WP/PBO MU6KM /F2&R3LS/]E%/@]##/&UN&OOH'4$L#!!0 ( !5^ M"4W9A_2FM $ -(# 9 >&PO=V]R:W-H965TSD*^J!]#HC;-1E;C7>MH3HIH>.%4W8H+1['1"\/P,1F MG\3\#4(_.XQ"\S_@ LS K1-S1B.8A@ !D !X;"]W;W)K&ULC5G;;N,V M$/T50^^->-.%@6.@N=D&6F"QB[;/2LS$QDJ6*RGQ]N^KVWK-X:%L/\22?(9S MAL,Y'"KS8UE]K[?&-+,?1;ZO[X)MTQQNP[!^W9HBJV_*@]FWO[R559$U[6WU M'M:'RF2;WJC(0\%8'!;9;A\LYOVS+]5B7GXT^6YOOE2S^J,HLNJ_>Y.7Q[N M!S\??-V];YON0;B8'[)W\\TT?QV^5.U=>!IELRO,OMZ5^UEEWNZ"W_GM6LG. MH$?\O3/'^NQZUH7R4I;?NYOUYBY@'2.3F]>F&R)KOS[-@\GS;J26Q[_CH,') M9V=X?OUS].<^^#:8EZPV#V7^SV[3;.^"-)AMS%OVD3=?R^/*C %%P6R,_@_S M:?(6WC%I?;R6>=W_G;U^U$U9C*.T5(KLQ_"]V_??Q^&7(5:O@1@-Q,F JTD# M.1K(:PW4:*"N-8A&@^A:@W@TB'\93 >=C ;)M1[2T2 ]&:1LTD"/!IIX"(?\ M]0OB,6NRQ;PJC[-J6-.'K"L=?JO;)??:/>Q76/];NR;J]NGG@B?1//SL!AHQ M]P-&6)C8QCP@3&)C'A$FM3%/"*-MS#/ I,S&+*_@LW(QPD:L >+7(&$[L:?9 M%7!V16^O+*:.V U=%0@C26#(%\$LI\>Q E(P( 6<*!+0@$G.9T[(V$F$"XLUDTX>7)B< M2$,$64> -2W.R,TW2<)%Q/-%Q'(*8042PT!B$ A9*_>Q,V%*J8@DZ=E%"9%Z8C4VR EUR M4BDDE;JD8N)J-6#2\^#- M;XPLG/4EE$5&0S(:S! 1]!7":.R$,[Q%,7<([9DT[MGE.!B"U@D$$=5;7@#9 M9/"FP,&NH#UJQK$^]81QT+'@=*Y\2 0+?P+ M()L,%BL.U$I[MGV.I8,C[8AH/*XD4-F=A-A$L%QPH!R"A$]'!585 52%[DD/(\C:1^(D4IZ"%UA]A*L9@GGR*#R- M).HD:2L@0.]'N\@IB$T$*X] >I%2(FZ_QF\$I7(%:'4!9#/&\B20/&G*V 4) MMP6?!MEDL- )U-+13F@$G:^Z1',54SHN3&HMF4>]!58[X:J=8+X9QFHGD-J1 ME?)!//T M Q(KC 1="082SU8@/:=0=#14U)5T M4A!-''>Q1DA4V9XZDKBR):IL>ER0[CE*:Y6RQ)<#7+,2="C.*6 $7=G@2US: MTBUM04\2*P"2OH!P54NWJ@6+J1L7Y'6#:UJBML$SA,+%JE#;0-*\'D'G:4XC MS2-?FA6N:@6JFJ9Y/8*N3+/"1:W/IWP^)_4$L#!!0 ( !5^"4T$Z?UO>@( -\( 9 >&PO M=V]R:W-H965T)R0'/,9+4DAWYPHR[&077:V>,D(/FI2GEF.;<^M'*>%&85Z;,^BD%Y$ MEA9DSPQ^R7/,_FY(1JN5BFK1R1C,1"A<#R<25;DF4J MDO3QIPEJMIJ*V&W?HG_1DY>3.6!.MC3[G1Y%LC*7IG$D)WS)Q!NMOI)F0KYI M-+/_3JXDDW#E1&K$-./ZWX@O7-"\B2*MY/BS?J:%?E9-_!L-)C@-P6D)4OL1 MP6T([IW@/B1X#<&[$[R'!+\A^ ."5<]=)W.'!8Y"1BN#U?NAQ&K;H1=?+E>L M!O7JZ'T^ M9@=@%O,^YA7"+&"K+I@-5P?P>MD(!MFH,;[&%#7&]>>^;<-"'BCDC810,.'4 M!P/X3SCU1TZ1K7^PT!P4FH^%T&!M-C4FZ C9,W^P-H\Q/2,+T,@",((&1B", M XLL09$ED-:)S1Z 8(GUB48K\NC'81L^.3:3ZQ, ^JF'.[H8W.%UZ?^!V3DMN'&@0I84??&?*!5$>I''T302 M^;71=C)R$JJYD&U6E]RZ(VC9?$Y8[3=-] ]02P,$% @ %7X)35^ 88[K M 0 M@0 !D !X;"]W;W)K&UL?53;;IPP$/T5 MRQ\0@X&E6@%2=JLHE5IIE:KMLQ>&BV)C:GN7].]K&T+(AO8%>\;GS)PQ,\Y& MJ9YU"V#0B^"]SG%KS+ G1)N:8USD"(;6 /?P?P83LI: M9(E2=0)ZW*:AS?!_NCXG#>\#/#D:]VB-7R5G*9V=\J7(<.$' H30N K/+ M%8[ N0MD9?R>8^(EI2.N]Z_1'WSMMI8STW"4_%=7F3;'GS"JH&87;I[D^ AS M/0E&<_%?X0KYG6KO?K.)W$R4S;)M"90!=" M^']"-!.B-T+LBY^4^5(_,\.*3,D1J>EG#H^) YK&X4TM'V$AC<)=O"TGV923;,A);^1,F&25 MAP91<).%K-I @&K\Q&A4RDOOIW7E78;RGOHV>H-/$_V-J:;K-3I+8YO1MTPM MI0&K);BS,EK[B"P&A]JX;6KW:AJER3!RF%\)LCQ5Q5]02P,$% @ %7X) M35:U;VS< 0 Z@0 !D !X;"]W;W)K&UL?51= M;YLP%/TKR.^K^2Q91)#65-4F;5+4J=NS Y> :F-F.Z'[]_,'191X><&^U^<< MGP/&Q,.1>B]\=R=6F4:N"P&TA"7\W?U)YM=9SD2"7M.?W>U:G=H@X(:&G*F MZIF/7V'*DZ%@"O\=+D UW#C1>U2<2OL,JK-4G$TJV@HC;V[L>CN.;B5/)YJ? M$$^$>"9$MPG)1$A6!.R@\AG"-8&9A>QUT5L^?&P_LAIW, M:R?SV(E6=JXQ2;ZR&ULE5CM;ILP%'T5Q ,4 M^_*9*HFT)/W4)E6=MOVFB9.@ L[ 2;:W'P9*@WV=07\4VYQS?>SK,">M/EN;ES-X+<;AUG'*]9UE>RGF4WX4:9*SE\(JCUD6%W\7+.7GF4WMCX'79+<76P7;SNPO]/89(DFH$3\3=BXOVI9V9&DJ(U4Z?K=![6Y.2;QL?T2_KQ=?+>8M+MF2I[^2 MC=C/[,BV-FP;'U/QRL^/K%V0;UOMZK^R$TLKN%12S;'F:5G_M];'4O"LC5)) MR>(_S37)Z^NYN>.%+0TG0$N CN!>)[@MP1U*\%J"]TD(KA+\EN /G2%H"4%' M 'J5$+:$<"@A:@G14,*D)4R&$BCYR!SYI-09=YJ4UV=H%8MX/BWXV2H:&QQB MZ39Z2^4Q7ABWCUEB&*^/66$8OX^Y MPS!!'W./8<(^Y@'#1'W,(X:9]#%/",8E?*KN#L$1^H_7+B+"W<1XKA:#U&K'-)%@PDO]P7<0-MF'19,B*OML@YSKVRRC\OV$=F* M;^Y]77;@$64+GW64;Q03X&("1(QJ4 RC&O0ZIJXC@C7$2$ZE#+R$&EN,YS<"3['1)_#,^1-/A+02D_^7V26+>A2:.";#RPU M/54HHI>JAR$>AS$>!X/'88C'89C' MG8L7+_F)X5M<[)*\M-ZXJ-[BZA>M+>>"52')3;5'>Q9OND[*MD(VPZI=-*_V M34?P0_O9PNF^G$&Y]YEG!QO:> M\W+H.&R])SEF#[0DA?AG2ZL<ZD9/CM+ G(S6WJB8C M>N!96I!59;%#GN/JWR/)Z&EL(_L\\9;N]EQ..)-1B7?D)^&_RE4E1DZCLDES M4K"4%E9%MF/[&QHND2<)"O$[)2=V\6[)5-XI_9"#E\W8=J4CDI$UEQ)8/(YD M2K),*@D??[6HW<24Q,OWL_I<)2^2><>,3&GV)]WP_=A.;&M#MOB0\3=Z6A"= M4&A;.OLE.9),P*43$6--,Z9^K?6!<9IK%6$EQY_U,RW4\U3_XP>:!A,\3? : M@N?>)/B:X'\1T$U"H E!7T*H"6%?0J0)45]"K EQ7T*B"8(P21LSZZ$S[Z'S#& \0V\5,!)N) #.! ML0^C3AASAW4123R ?<2PCQCH>F.O+VI,>!'%AV,D<(RD6USS4PI C/K/[D,6 M28^-\WH'U$IH "J=&UL[3UK<^/&D9^#7S'EDW-2%<4E M*8F2;,=57.VNLXF]4E;:.%>I^P !0Q)9$& P@+1TY<=?/V8& V! 48[M)&>F M*LE*F$=/O[NGI_654J7XM$HS];O/EF6Y_N+%"Q4MY2I4PWPM,_@RSXM56,*/ MQ>*%6A5/Q79Z5 M2P5S8AFWO_ZARH;B9#00D]'XHOLQA8]C_T<+S\P+3WNX'O%>+A)5%B',>Q>N M9'O4U>S=N]G-]?>O7K\?B+?OKH8]RUS!QD68PH:Q_"3^*#>]T-UMUIU=QJ/C M/[V8]4ZYD462XYEB\2HL.[,-RH+?_,:'EQFL$=,Z;])PT?Y:%E5GP7K&*ZFB M(EG[\%I?1R(6^)0<5V5J@0V MANGM:7=%B+\6MYO5?9YVV>/F52_9]-$U]=[ KSNR\*?)4[,)<=ZY5WFF\C2) M 3&Q>!FF819).! (L +9^W#[2AP>''66EY&5H/,^FH5*P2)?=#Z':DG"'N$_ MY-^KY"%,87P'LIM"KL,D%O(3Z!G5U0!W>0DGBQJ[^X7:AU&\G>?@5Y5 MLGB0GWTM_'NE.;!7*8O5TV!M&4 ,O' M?2DN!Y>G%X/1^3E1X6)P=CD>G,%/>FBB%%(%O^6U)(JP%*#:I+4&- 86*[N M 4[#Q )66,NH3!YDNNFH9V"#:E6E)"-YN81Y69J\+>]JBP M>I/."E=AEH4@TX^@4<#YS:*.=D5JU$:C_?5[F2R6* /A U!J(3VB SI()1&Q M49RD5=GE\:;\7#64-VV_DQPYJUS[5O%A)?7\_FH99@NT&A 60;R4HF9!.L)) M,^TT1!N!X81*.0I:U$S6XVHT@/%MRM3NCO.1?">S=?7T4D_3?HN6(T?Q39H_ M[DB=:ROW,[3C?H<.;++X[7]=3,;C+WUG1)K026#_R 5-5?$*ZR=\WIYIQ!YH7*S6P0-D6WS+KP_-4KB M7A06"5L.KX^EB3"5DN2IU-HVM%AO3]*F?3ME7J':1+2M"P H69,WM-']!A,X%L"TJB3)#]Z/0>M1E)&2O6U H"#Z9T;9K%(5(1?IF8Q0TM M.@QG<;%&90R65=QOQ-R>=0L^_B)F\=\J5?KL ZYJ*7(8.U2BB&GG< H$Y5XN MDBQ#6. \:PH@GS-=HB?=-_&V6JU &G# +:BM!)Q1S'[H@ GWO 'AB3RG]PS9 MXE4GQY>1G _X,M!K: W^*2'\H0^!Y@N9#8&%6,&)ZTS, MJ@405TS.T*<:P?^6SG81Z0O8!7!LEZ[W)Y..S(F[!:!#W\F', Z1M7"5E2P6 ML#],<==\3$JF(NBQG%9^!!<^W1SGCUE#>0T\*GD@0K.) \10S%008EA4I20/ MJ@)/C;=O'(BTZ?F7BO&!R#0G]!H TAD%X3 '!BU![$F\Q1B+]^JP7VEDDRB M1K:.FHMCX[?B(3+YV#AW4)^;X"HH22<+)O%;580R;=.3[$X-L_BVC(?B$*&9 MC+ZD+_H#3ZBW=O;YV@^M"[ MK,XXV=5%F*8(^N,R 2(]PA'%4J9T3$R]Y8\!['@OEV$Z;[,.$7&!!COO,@D M\,@LA>'OP-\B3-_*=\[C>,T#ZAG&^+GD1"L% (N!W)K;^ FSF MD;AH@&4R=\UMO^0LCSNY=1QGWOMPGHC7/Q1A ), - !#"\U R/F<4PJ^0[39 M#.@3(0>&XG+TN6@+;IML!*%8)1G$I>7&^B\!#!O;Z4!;"]Z0=%Z3,TEL5V$& M7C7Y#*"%TBJ6*O@V?$C$'XM0$3N@/KEZ?3V@3>V"^O=WUT/Q73&D7P': :@E M^.OIALQFD8 G"X"L 5VK, +I8U4E/Y7:;?R8Y8^IC!?2'#!"M-PG*E" .A K M3K@1$NL5<7 J.:4*(20(/ @1K,'[D),+NEYJ,^^.B)TPLUP6>;58DD3*@E(/ M:5AET7+8B$;A4/<2=P+O(JXB"D5(5P6_E_<%Z)P/&4!7**2#*Q=X&DK(Z9.] M 3N>D$,(_%-6,1/QFM+B8K8H)!.A5DBJ@O/J*$^OD8!_DR%:^.>@E-$RR]-\ M 60"WV8.BA(^WB[3?)6+[\)%#.YH,FR8.W0G@*7O-8DB(&*Y#,L EW>/#* A5T\@ M$\0<\Q+L;2W:.@W9-3&H#<"11 [3!*_1"6L\)!14Z1&P2H@.>,['J=E FX!$ M:0ZZ_QL:UEX.C!,550I7N@>W !\J$9Z\S3XL\FBW\'_QFIH#.); M]IU/91#I8B MC!_@W\ TK+^02K0S$JHR^0 3;P$252-[T#"6A31'8 9ABI-@D^+"P5J0[0)O M*5**)^!'HM2=&OPVWOF"J36[?%?AN(*@DX(P2%BJ"^N<=8\STN,0TG. MTAQ0"J?-< BI!3:W!)$]AG".0=F P@]R6$=1.F &A1LX? +Z;JV/B\<#(V53 M+'2^&3 ?8-LZMQ]NQ3>SV8WQ*<42_#\@I\S([F$$'*.;FP/+XT*NI:/0X/;U M55!4J;Y&*"R&@,6T,LC72688W#H=[+N&-AQ6XA 3+^ JZ+B5T04+8F*,XNIZ M[!$E:2#T1B1E$C4\.IMS\AM$"(*\=L/ ^DBK,-9LQ;X:,R4 25D04!3)2L>] MBK@'-;U9/R'2(?N25Z)YS5F'3"ELBF8!S:.'?[WD5LN\2E$3HXWF:Z \^QLX M) 2\9=2VY&^5!'TL@@,#>NF[^S(ZA1-&I K0AW;8T[SW +OE14Y[<0YZ$.M^'8&ED_1 M+Z# 6$/HR1YGE+J&:%<8W:)Z*4D^.D+RG>2E/NSO9PNT9$6_0R419\//]0) M#?;=&O>G'+ X*[=6U6#C]D]N(#$+)'$3]*UB&5&*$FD EDCB%+!*:_KG'-C2 MC35Y-7>Q9@P1IBH?!'TH8NJTU_RK/K MJTT4@AR\E$X*L>#?_R QR<1#X1@88P7Y@X[FW%"0KAZ0>3V&?79[)::C*5E- MEFP08;1!-HI ?&*NBPP5!1Q\DZ$P^P#()Z685P7F'T!U*LPB4FY$H_FQ!M(Y M#X5/81$;N>NNK@V"3G&T U6#;"> +^S5X#> MG\13*#ZQDX$PO#!#FT955NAMD#L),"< .FG=-8(@Q4>Y(=HJ=C,^K-'MPH-2 M%NI1Z@ 7SU^'8'[,%9*K*O0)7._*I);Y;B*/9(QN'#C.DEU>$P'Z%R[S $+# M @6^2-1'I)'*@5=+:Q @:M@8$9F#MCU6I5R#38@EA+RH@DGUH4_G /FW*EXP MGZ,KHWV%3+*K -\?0"^0(VZ,($E5H+%7;XB?B7PEF!4;PJ8;0A\=KX[(P$Q1 M,,6I$',\ :L#IN8;0@#'_6%18 J8 22KPY=D*+"(7JL#.S%51"Z04>TPU-9W MU11!/:(4S@%57A7F*$JBHRI,DM/*#C,!1>/ EWC9&N#">H]Z,>VWQA(C$?U9 M:I+CH$&3%0P*AL+>7YNJ0$P.ZCOIM'&WCUM\F8L =PLRJ-O#FM^4C,4GOU M;DE ,M=VJ43N[,Q''X+F<+$."8:>TKLG9:L)+0FFQG5IS!T679@?J *#M+7F M5[[8YZ1>[3$T;. &U&&Y1,2_,N5'L$ROM408G%2&20.!V<.KFP()-X=E,$V* MB 16CO2YN<)D^UDC8E3 MF]D"I+PNQR+'W$J!/AJ8,\*V#L"WEQ7K\-LR,R+LP="D76735U;.GNXG.F#L MX$'$E?4,U!(4\C%%%UE(4HJ+-9,,[,];^CF6YAI5)+]W4"VV(!:FF$*GLEGI MHB#%0*5(EZG@BF0J%6L3<":).\PM"#IM*8LA4$IJ6821>F/M4-#5$F"698M& MVF")OM8Z)S!S-7II9[2+0)X""P]"K(=2I48^@X%@X0:WG&1K@'#/T1EZ)EB. M;F77#NAL@1Z+HS8[3A3R#]_$M,]:;P0>!" Z*4P:Z]L\6QQ_"UP: W\1JAM" MRH*DA10#-_3V6/F@H&+]_W%*LQWKZ*HD(RG(Y"L=L.$$'2IC2%A2)J&A0>F> MU0W1*#M%J7_KV 4>#M?NA2N'%NC4BI G897EO:#D$4DDNU2,WC SF*$\S]R# M'>'%#A>$L+X9BM=6B]SY'1%E+A$H(1_DUJ7B:B-O-E[LF(UG7X+7MK;5"P.' M>:A@D>KDIGCV\ .C#ZM:M%R%'UTE2HH(7.+5FCF;2!Q2'8-&+?I_N FK4$1Y MG[OWM)*T!1U97?)H?1"5?#*944Y<=Y?"V6!7H[+B5"UY-*S(V?DS^33,]-2' MI)#Y?N-@@F61;TK? WQ9F6)=##TH<C3')*9KW7Z@F<3F^>.] 2G^84(#_6C6 M!P[)$7U8P@OQ0)IOI PH>C'7@%Q1R34W8:3O9^YT6LBD@) 6(?IO1(8(%!WB MQ0(AG'#MJ<7I/B2,D/4H8933C0J^,\'2ALB4:+@ 8X*[Q@_JS+J.!@\WYR=M M5'C@E#B&=U8]TN4,5#=B$TKZNI<4=R,7 M:JJ.VD@TY8.AW'V1A97R*[+G9CU3B)29]2U$N7"7 8 M=,]L-MP7!-C[TJ"^S&O4-_M5'NNV++8RR?<51+^MTDG9RS^$684!:>T)-63D M]D. ;S[QZ_$(5,%+DQ0"X._11/(#%V:[B]'9T1?B*@V+9&Z35^#%)#I[26G< MES9A>U-!.!:Y>::2E9*^8Z,<&,?CY@&J8H(E1E"1R\,L0\UB^.4I9CL?",ML MG6M$RVRHB_0O07=AX1ZY5UX010O$Y\.D;X;\T 3/7.R2Z/H=%8/XJ5_LV[/"OD'"(Z\G[?2&UY^.T+NZ*'M]5]2;0_&8^.)R,@ M_PTX+DFU$K,5YB!,')H!M)::G8S A6IJRT0%5F&Z M8E$/P/BPM3FP%[F.DE]9.PI8>6C4F8[GV;CU 8%[I4XUQN0 &L7:J(_G#)0] MLRYKT161YJ<6L,^0A7/-^:YAM^)1ZL(3\9(3**HV^:CVP#?!*Q>M]1J5[0 X M/AC@U^$PX0;K*N'W5U1! ]2%KT']%7Y;=':CP4# !B?U"8O@XHIGZL5@1[W8 M7)@%X0DA>%)8>#*U;KW*1->?D"'6( -Y'4!15O)%MTI*L&/NQ0 M? -.*F7A&$6USQ!H*:8G$?OS+" P'T% LB^Z&#F5()X8-T+K4"2E]K-Q,#?1(FOA8' M*RHY_XQ^!@")[&(=42?;9,/J!C")TN4J.!5U5C,+0+H!F'2K6 MZG[(2= SS\;6J6UE'70B*=3O"*@P ,X0:&CN&F=2_D-IFVHS)9SHU/D_?E^J MS+V.K2CA+%T8+66+M'5Q6L"DE?:2J9LQ\6 8[\_PL9HYBG".LA40+JODBT_D M+!_53/1TJ4ZHX14E#OS):ZJ0.9@OM7!-58Q['I,5Y/9== ?Z%E1H?ZPY= M0=() UWG1V_,PI+L->6L"E!1B'(U<(JG(K#I^8HZ+W#MA/\KY3XE_CHK.?.% M4<0R63>&TQ;TX,?]=:.:'A?BE[!@K]&NF )]Y3L*W?BQ5XIJUM1\:*4(!ZQ9 MRMR1U#ETNH!?+,MC+#P).$W.*1&'#R56NG.Z#N_6*=*GW,9C3IG@1P!MP][: M4+S+&^6T0,,D1O5C!:5>F6_[S'D"?;O5>>2>'COJP;B/I%K[D" M:#LL]8V$\^"W_P4@MD@1AY,CT0"B$8,#^0 W*\JI.>_$ G<,)OS66$225PK? M/F2+<&%*:VV-=NVFZ-H9MZ2:\^I\RT&%6_AX;2->8OF$<'F'3;6IOHGHCMO- M$>M<@ ZGA=Y:$46 M#)"DBY #6[S#]96F-MV4H=MG%2R5F'%QWE0DV4.>DO\-C)L?JR)%4#6%XEL>$@K0:'2_'N?5 MO7-K&[0S8^:2@._2J2:T]^A/EW#'.>'$9$=;X2@6@[EO7==P-K(BVJ!RW&*O MS5O7&%1TU"F'T 9(RZRYV/2/=;+S_-P*C;I^X6L+3RU02=:ZVS:4WXXJT3$> MII%73]L6?YLKUOHG1Z+=!JS[B_;/^3PXF)P-QN$:'6+XW2+H'(S[/3GG1XTV M=&@SKD$**/H\]QD-,,L0^,!IJ$O.7$P')[KMEK+/6</E-^KT^K5W0._=*$*@=BX)E8#-06UH+'<*_DA1 MPE=2"6(&OE!!O2KE)WR IK@$@=!V-G*PIA\LF,KER:G.^+-CQ=[U@R]2Y%WY M$@6P%J/4Z#WYYO5@?#(9G)Y=U$%]&]R#\?1\<'8ZJ4WT; &GCOAS6U#!88= #>:#>GS (LZGAZ\GDCV,-B[K;?/1Y.+S[' MZ'H\O/B\YAZ3#W34C?[5Y2"H+PO[&&5@?#H-##WTNZ,&.8#"ISK5%VR7XC$HA[-=R#&]'*$R M?0XYZ-5J\*\D!_HTP3]%C@D<^Q),:3\]3BXO 3&G+2E^*;XW4HQ:?X<: ?U ME:2\*:T3K:''%Y?"6"VJI,1",?K2US>RZ=;4::7&(6SK/RZWJ)MP^!=[FF4 M2;79_T0'3$S$8AD4!%/:0O&BRZYD)U\#!D6'M$&/=:8&$QTQE4W'JU@4!/0SA:F8,B[4? MK=^"F9I_"A[J& 2OE77%24BW);H 1Y%];$,@+RZ?>= [&!P8_8,E!>16U"[;@2 W M".2$NV:VQ[Z$L2=G4S(,!X*4[?CB&-2J'LX-^29V3$]+S3M?L\;ZFW,M\F1N M[.RH^1BA*;Y.,7)=UA^8Q.6N15HX4C_X^Z+Y])3U,SV"<.PMA&;OZY? MXDV#4:D>I)BEC;'2Z=N^ZC-/](@]?#!'SM-8M;I%\+BKT5'_@MS%I!\_>^"@&[8@;S2-Z<'I:#(X/QUK%QRO:M]S:ONDFT.Z[[_U MLQX[LO$ 0KG/JIRG]SN981<@W#J+M2&S> IP*[ Y59$I;]J/O1 4;5+F, M+U\I]4H(;N3\,(-5<2U) MJ8#_/I9F7;9, "@ M%%DWZ+:TAMS9N:8 ML)&LV=3AKBGQNW!2)7QQ$4S.+'FP9K"154+W13;ZV-1/,O!LB.F#\71P.CKA MCJSH<=P#*^.'B\]KB>24MJYUJ!\]Q"0$%&[R7%TLKE]8U *-O0_.+SFLT&G$ MW&TY-W*%D@]"#1[,03!9G]!5#)QEP^ODC]B,) _J/J9\Q<9;AOZZ]XZL\1\& MN/%W8:7JMF^VQV6V>09GQ\GQ<%'>X N^&1A;@ OFU9A_K90TTV M6ZJ%&"ATS\L+3K)P?-&D'>.;Y@.;>!%E*@U8H7T%*L._&B'P*HQ0@( M=N13N:LMZ0+D7H%CPCX"R/<"\)AI#^6^U.GY^KH72YUTI!(8]-5<2)K0<*!X M#@=.^\R1_Z'&E#R)0%."B*,-MGL^[6II'#R2"\D'')AW0.[P1+4UC0D,&2D. M0DB* V(KW2J7FAST_2&%7306]FL-?LT:J^:78!>-U6S..3'XY-@4:8VE9D%3 M9 _ U%V<6^U &"+QKW=[4B5L0\U(O^O1Y ^P_Q[BITGUSA\WNK4R*%X_^/X6 M36? DRKWXDAT)\T4_=F.C+UBJA7%=A\79V?'8R"<<^/.\P*>IW.& T=7F#=2 ME%NRSZ4:+R_(V:4G4[HXD>H,=;<9^A-=A%@!GA#0 ;,OWCO-P,DLH?=A2P?Y M5HR_#+UOU;@_D@L4J2P-;PT?I;'JHVFMX0&5;_&QW9 )XLB6N&_MO->RZ,V$ MB/; 5(MR=1*SOY,V:[_(R'1SLQX4YVOVQ=QZX;Z3];]E(NWM3VFIO_>2 _]S&VYUK+'\?[AV' M[=MU[]MU>\_>\X>)W>[=.PS9-_C>-_C>-_C^CVKP'9@&W^(G;?#M_7O5-ZU^ MW[U_U'K?%/Q7U!1\6ZWOOD?XOD?XOD?XOD?XOT./\,Y?)'^Z9?B/F++O,OZK M[C+>K5KU-AW?ZWA'<4#G">DM2$!<<6NN[^O67/K-C1+7K:9[K.FTT2/IW?>R?0-))=@7M+[6!KJ8DI?L M_'F']LM+T)F8O T7G;4NL3OFYUU.WZZ,35P9XR/89.VKS_PY];GX"?1YIY[4 M/ H5?_V.1*;3)>*[]DO5+6@=>]':?7S=NUGS+V=X.+P??OQK#'W+(F<4:+JW MP-YYU=NW6+M+_/,$L6G^GC/S.WR/,KGT-P8A01SUB/!U!$Z3Z53N_3CNF>GV M(.ZT#VD7ZF%;XH[0AFP3M&R3:;,E=NW!!V(X';5_>=?30^Q)<+!2E9\,TBM# MTQ#86QYB7>=._^"MNLKT/[.M2;>.?LC98T:!WLT4_OPM>CL&Z,]UO_$^ 7 P MMH)@O.+\44<73$]\RN"5:57^'O,S9@OQ#_&=#G+[=J4^YKNO%GYZ8K4+CZ+2 MOI7Q./LF6P>KY>WU,K:=@(Y?^Z/M<^T'Y^63X(Q/N&C75-;VCG.']8["-M6_ M?V*EF[JILRL'G%?:LVP44?9BM$#89 MH3\0:="\YP#=F* S G-6WHC ;\1Z@H%G]"3=P2-JN GZ:#57]WC.K@^PXQS7 M-=AQ2L-)V7$.A1^F1>>VX,:$>N"!RX7LL,D?P@SVOFC ZP^21EOW<>$SY[-V MM3Z;4^C@V[O:HW&NGV#6LUV^X8UVY?N M)*\;,=K.WW^H,AN"]_&N.V8G.=%C>FC HC#9NMQ[W=5QSMT.N:"L$]'U=S+= MC5F?XKCM!!CW$NI5\]EVW336?X[FLA//LB^4*K_^/U!+ P04 " 5?@E- MZ6.A,4D" "%"P #0 'AL+W-T>6QE;#OA7%/ML"O7BRG#G]]9,LOR0>Z]9L'4T^Q'?/2<\]DLX^ MA97>,K@K #1J.!-5A NMRW>>5R4%<%*=R1*$B612<:*-JW*O*A60M+*3.//F MOK_T.*$"QZ&H^0W7%4ID+72$+P8(N?G7,H4(WY^\_E9+??4*N>?LS6SFWY]> M3?&3-G"*D>/XF$8X6%Y@[\])SWS[^R6U"T\2+)Z8X#'V"?7RJ=H?53XAO[3D M7G<"<9A),1[$.7: R4XXH UA$;XFC*X5M;,RPBG;.GAN@40RJ9 V%6#4!1:I M'EPX<)XMCHZ'4R%5F]MEOMJ51F"NR#>8+/$YH'R;)6JH4U) FP#T4APPR*T?1O+!/+4O/!K66W!@I M);D4I-70S^@,0YL 8W?VS?F:[7$W&7)C[)'X&%D5O6E6W9GCJ?FMY%TVQ[U+ M>Q@O*NE&Z@^U68YH?5L\<*L@HTWK-]D@P+"3LF3;]XSF@H-;S&\3!@2[(N4*&MV74Y,=JGE^A)K_]3[G($ 1MBO: MU/Y+WN7_K/C\\N\EMU^5J>"7M:O/+=&VZB,0N3@&D+0_0TIK_K9-.%Z\XQ]02P,$% @ %7X)3>6V M-&V< @ 1!$ \ !X;"]W;W)K8F]O:RYX;6S%F%%/VS 0@/^*E2?VL*4) M% JB2%M!4R4$%:VVYVMRH1:QW=E.@7^_;R_RW%4;5."^F"UJNM,8J\#3I7W,W=8BU&Z#Z%6;EZ/1 M::Y ZNSJ\C#6PN97E^'DA\1G]]8>+@547NYP!>MI-LJH7QYU[ <]'/=$%_9? MF$S3R JO3=4IU'X/9;$%+XUV&[EUF="@<)H=N@C0M;C17OI7,=?[H:AO)OJI MY_4T*^C<@Z=G=M+)=8N9L!>2;MAY703P=) SNC:MK&GV6GR#%G2%8MG')@(L M&<#RPP#%T0(BR&,&\O@_0BX#1'C "=.(^RW:"/*$@3Q)"SGDFAE%R;5![2A% MQ*V)EWO,0(X_+)(S<)L(\I2!/$THSE._;TCC7?+G#G*Q.88ILO[8,95L>1D4B;_[H@P M/XLE#5EW+89W]2>QQICLQT=BHPSSFXTFYY@RL6,&F,-H7F,SP.2,4R8VSM]W M$'UL8TS..&5BXPRV$6Q!*CGWE+U[\L./AAH;J;&^HRD3 M?W;4^P<5OPMB]3@(PT$H'K0.!ZW%@S;AH(UXT#8:^! 1ODQ0:&;) W&QBT05YM8-@& M>;>!@1ODY0:&;I"W&QB\05YO9/1&>;V1T1O_X:S-';;E]49&;Y37&QF]45YO M9/1&>;V1T1OE]<:9WJ[6EHIW;YN^P$ + 1 3 M6T-O;G1E;G1?5'EP97-=+GAM;,V8W6["(!2 7Z7I[6(1MKF?J#?;;C>3[048 MG%HB?P%T^O:C59?,=(F+FIR;4CAPS@.D;%+RCX1$T8#A ML7(>;([4+AB>=BP>= V' X(L+9!#8-4INCG(Z?H>9+G8JG[7B;>E)R M[[42/"EGR)4GE,7+.F>)>6Q2YF@LR1$5#A>V_;SN M;04A* G_0G-UK01()Y8F+ZFB#\!E; "2T55L> #YGH*R\QWOC(?TRDU.3-:: M_)I078XC;33T W21=^ _P4BZYK13/Q\'0\)QC83C!@G'+1*. M$1*..R0<]T@X'I!PT"$6$"Q&I5B42K$XE6*1*L5B58I%JQ2+5RD6L5(L9F58 MS,JPF)5A,2O#8E:&Q:P,BUG9!Q"8\ M "L" 1 " 9D! !D;V-0&UL4$L! A0#% @ %7X)3>FE)?UR @ >@@ !@ M ( !^0@ 'AL+W=O&PO=V]R:W-H965T&UL M4$L! A0#% @ %7X)3=UA 8>D P &1$ !@ ( !(A$ M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ %7X) M388#(6>U 0 T , !@ ( !#AL 'AL+W=O'@ >&PO=V]R:W-H M965T&UL4$L! A0#% @ %7X)33AK#HFT 0 T@, !D M ( !QR 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ %7X)3:I_#;ZT 0 T@, !D ( ! MAB8 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ %7X)3<='"L.W 0 T@, !D ( ![RP 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ %7X)3>8S49*K M 0 0 !D ( !KS, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ %7X)303I_6]Z @ WP@ !D M ( !5SP 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ %7X)33K):UUP P 1Q$ !D ( !/4, M 'AL+W=O&PO=V]R:W-H965TI) !X;"]S:&%R9613=')I;F=S+GAM;%!+ 0(4 Q0 ( !5^"4WI M8Z$Q20( (4+ - " 5-Q !X;"]S='EL97,N>&UL4$L! M A0#% @ %7X)3>6V-&V< @ 1!$ \ ( !QW, 'AL M+W=OP$ + 1 3 " 1YX !;0V]N E=&5N=%]4>7!E&UL4$L%!@ C ", 9PD ,IY $! end XML 39 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 40 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 42 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 60 112 1 false 20 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://cannapowderinc.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://cannapowderinc.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://cannapowderinc.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://cannapowderinc.com/role/StatementsOfOperations Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Comprehensive Loss (Unaudited) Sheet http://cannapowderinc.com/role/StatementsOfComprehensiveLoss Statements of Comprehensive Loss (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://cannapowderinc.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Summary of Significant Accounting Policies Sheet http://cannapowderinc.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Sheet http://cannapowderinc.com/role/GoingConcern Going Concern Notes 8 false false R9.htm 00000009 - Disclosure - Prepaid Expenses Sheet http://cannapowderinc.com/role/PrepaidExpenses Prepaid Expenses Notes 9 false false R10.htm 00000010 - Disclosure - Common Stock Sheet http://cannapowderinc.com/role/CommonStock Common Stock Notes 10 false false R11.htm 00000011 - Disclosure - Income Taxes Sheet http://cannapowderinc.com/role/IncomeTaxes Income Taxes Notes 11 false false R12.htm 00000012 - Disclosure - Related Party Transactions Sheet http://cannapowderinc.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 00000013 - Disclosure - Notes Payable Notes http://cannapowderinc.com/role/NotesPayable Notes Payable Notes 13 false false R14.htm 00000014 - Disclosure - Subsequent Events Sheet http://cannapowderinc.com/role/SubsequentEvents Subsequent Events Notes 14 false false R15.htm 00000015 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://cannapowderinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://cannapowderinc.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Common Stock (Tables) Sheet http://cannapowderinc.com/role/CommonStockTables Common Stock (Tables) Tables http://cannapowderinc.com/role/CommonStock 16 false false R17.htm 00000017 - Disclosure - Income Taxes (Tables) Sheet http://cannapowderinc.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://cannapowderinc.com/role/IncomeTaxes 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://cannapowderinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://cannapowderinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies 18 false false R19.htm 00000019 - Disclosure - Going Concern (Details Narrative) Sheet http://cannapowderinc.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://cannapowderinc.com/role/GoingConcern 19 false false R20.htm 00000020 - Disclosure - Prepaid Expenses (Details Narrative) Sheet http://cannapowderinc.com/role/PrepaidExpensesDetailsNarrative Prepaid Expenses (Details Narrative) Details http://cannapowderinc.com/role/PrepaidExpenses 20 false false R21.htm 00000021 - Disclosure - Common Stock (Details Narrative) Sheet http://cannapowderinc.com/role/CommonStockDetailsNarrative Common Stock (Details Narrative) Details http://cannapowderinc.com/role/CommonStockTables 21 false false R22.htm 00000022 - Disclosure - Common Stock - Schedule of Warrant and Options Outstanding and Exercisable (Details) Sheet http://cannapowderinc.com/role/CommonStock-ScheduleOfWarrantAndOptionsOutstandingAndExercisableDetails Common Stock - Schedule of Warrant and Options Outstanding and Exercisable (Details) Details 22 false false R23.htm 00000023 - Disclosure - Income Taxes (Details Narrative) Sheet http://cannapowderinc.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://cannapowderinc.com/role/IncomeTaxesTables 23 false false R24.htm 00000024 - Disclosure - Income Taxes - Schedule of Deferred Income Tax Assets (Details) Sheet http://cannapowderinc.com/role/IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails Income Taxes - Schedule of Deferred Income Tax Assets (Details) Details 24 false false R25.htm 00000025 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://cannapowderinc.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://cannapowderinc.com/role/RelatedPartyTransactions 25 false false R26.htm 00000026 - Disclosure - Notes Payable (Details Narrative) Notes http://cannapowderinc.com/role/NotesPayableDetailsNarrative Notes Payable (Details Narrative) Details http://cannapowderinc.com/role/NotesPayable 26 false false All Reports Book All Reports capd-20180630.xml capd-20180630.xsd capd-20180630_cal.xml capd-20180630_def.xml capd-20180630_lab.xml capd-20180630_pre.xml http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 true true ZIP 44 0001493152-18-011258-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-18-011258-xbrl.zip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end